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Atrial" fibrillation" (AF)" is" the" most" common" cardiac" arrhythmia" and" is" associated" with"
significant"morbidity"and"mortality."Historically,"antiOarrhythmic"drug"(AAD)"therapy"achieves"
subOoptimal" efficacy." The" last" two" decades" have" seen" major" advances" in" cardiac"
electrophysiology," with" catheter" ablation" now" becoming" the" treatment" of" choice" for" AF."
However," although" outcomes" for" paroxysmal" AF" are" excellent," the" optimal" interventional"
strategy" for" patients" with" longOstanding" persistent" atrial" fibrillation" (LSPAF)" has" yet" to" be"
determined." Catheter" ablation" in" LSPAF" can" achieve" a" modest" degree" of" success," but" the"




(CASAOAF)"was"a"prospective,"nonOrandomised"clinical" trial,"designed" to" investigate"de"novo"
patients"with"LSPAF"and"left"ventricular"ejection"fraction"(LVEF)"of"≥"40%."Patients"underwent"
either" thoracoscopic" surgical" ablation" or" catheter" ablation." The" primary" endOpoint" was"
freedom"from"atrial"arrhythmias"after"a"single"procedure"without"AADs."Secondary"endOpoints"
included:"clinical"success"(defined"as"75%"or"greater"reduction"in"AF"burden),"multiOprocedure"
success," change" in" atrial" anatomy" and" function," and" change" in" AF" symptom" score" (EHRA"
score)"and"quality"of"life"assessments"(SFO36).""
This"thesis"aims"to"investigate"the"interventional"techniques"used"in"the"management"of"AF,"
with" the" main" focus" on" the" CASAOAF" study." In" addition," the" Complex" Fractionated" Atrial"
Electrogram" subOstudy" assesses" the" atrial" substrate" and" its" role" in" AF," whilst" the" Cardiac"
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ago" from" ‘The"Yellow"Emperor's"Classic"of" Internal"Medicine’"by"Huang"Ti"Nei"Ching"Su"Wen."He"
wrote:" ‘When" the" pulse" is" irregular" and" tremulous" and" the" beats" occur" at" intervals," then" the"
impulse" of" life" fades’."1" In" 1628,"William" Harvey" observed" ‘fibrillation" of" the" auricles’" in" a" dying"
heart," whilst" Sir" Thomas" Lewis" in" the" early" 20th" Century" was" the" first" to" document" AF" on" an"
electrocardiograph,"and"described"the"fine"diastolic"oscillatory"activity"as"fibrillatory"activity"in"the"
atria.2"3" Several" mechanisms" of" AF" have" since" been" proposed," including" excess"multiple" ectopic"
activity"(Winterberg),"singleOcircuit"reOentrant"activity"(Lewis)"and"the"multiple"wavelet"hypothesis"
(Moe)." 4" The" latter," based" on" the" notion" of" multiple" reOentry" circuits" with" selfOperpetuating"
activation"wavelets"propagating"and"colliding"on"heterogeneous"atrial"tissue,"and"supported"by"his"






epidemic" is"predicted"as"the"worldwide"population"ages,"coupled"with" improved"survival" from"all"
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major" cardiovascular" conditions" such"as" ischaemic"heart"disease"and"heart" failure."Data" from"US"
population" statistics"predicts" the"prevalence"of"AF" in" the"US"will" exceed"12"million"by"2050.6"AF"
independently" increases" the" risk" of" stroke" 4O" to" 5Ofold" in" all" ages," with" at" least" 15O20%" of" all"
debilitating" strokes" due" to" underlying" AF.6" In" the" UK" alone" the" cost" implication" of" AF" and" its"














The" pathophysiology" of" AF" is" complex," multifactorial" and" still" not" fully" understood." AF" is"
associated" with" numerous" medical" conditions" including" ischemic" heart" disease," hypertension,"
valvular"disease,"diabetes"and"thyroid"disease.1"More"recently," lifeOstyle"related"factors"have"also"
been"implicated,"such"as"excess"alcohol"consumption,"athletic"levels"of"exercise,"and"obesity"in"the"
context" of" obstructive" sleep" apnoea.8" Furthermore," there" has" been" increasing" interest" in" the"
genetic"associations"of"AF"with"several"epidemiological"studies"confirming"the"heritability"of"AF."9"
The"aforementioned"conditions"may"result"in"anatomical"remodelling"of"the"atria"via"dilatation"and"
fibrosis," which" in" turn" causes" electrical" remodelling" due" to" altered" atrial" (slow)" conduction"
velocities"and"refractoriness"coupled"with"altered"autonomic"tone."As"the"disease"progresses,"this"
electroanatomical" remodelling" provides" a" ‘substrate’" for" AF" maintenance," and" the" resultant" AF"
becomes"more"persistent"in"nature."This"observation"coined"the"term"‘AF"begets"AF’"and"it"is"this"
‘substrate’"that"Moe"et"al."described"in"their"‘multiple"wavelet"hypothesis’"in"1963."10"Their"use"of"
computer"modelling"demonstrated" that" the"perpetuation"of"AF"was"based"on" ‘fractionation"of" a"
grossly" irregular" wavefront’" resulting" in" ‘multiple" wavelets" colliding" with" each" other’." This"
hypothesis"was"subsequently"supported"by"the"experimental"studies"of"Wijffels"and"Allesie."11"12"
AF" generally" begins" as" a" paroxysmal" rhythm" disturbance" and" evolves" with" time" into" a" more"
persistent"or"permanent"state." In"the" ‘early’"paroxysmal"stages"of" the"disease"course,"pulmonary"
vein"(PV)"focal"triggers"are"thought"to"play"the"dominant"role"in"AF"causation."This"is"based"on"the"
seminal"work"by"Haissaguerre’s" group," that" showed" spontaneous" initiation"of"AF" is" provoked"by"






AF" ‘maintenance’" being" discovered" before" the" concept" of" AF" ‘triggers’." If" one" examines" the"
temporal"relationship"of"these"discoveries"to"treatment"strategies,"it"is"clear"that"this"chronological"
mismatch"resulted"in"confusion."For"example,"after"Haissaguerre’s"paper,"there"was"a"notion"that"
PVI"was"all" that"was"required"to" treat"all" forms"of"AF."However," the"encouraging"outcomes" from"
PVI" in"paroxysmal"AF"were"not" translated" into"nonOparoxysmal" forms"of"AF,"and" it" is"now"widely"
accepted"that"PVI"alone"is"an"ineffective"interventional"strategy"in"nonOparoxysmal"AF,"based"on"a"
wealth" of" evidence" from" both" catheter" and" surgical" ablation" studies." 14O16" A" number" of" other"
mechanisms" have" since" been" proposed" including;" PV" and" nonOPV" triggers;" the" intrinsic" cardiac"
autonomic"nervous" system"and" the" rotor" hypothesis" 13,"17O19" Each" are" likely" to"be" as" valid" as" the"
other,"but"the"complexity"of"the"arrhythmia"would"suggest"that"all"these"mechanisms"coOexist"and"
are" interlinked" to" varying" degrees." Furthermore," the" purported" interplay" between" them" would"
explain" the" challenges" in" treating" this" arrhythmia," and"why"one"uniform"ablation" strategy" is" not"
sufficient"to"treat"the"whole"spectrum"of"AF."
1.1.4!Principles!of!AF!Management!!
AF" is" characterised" by" an" irregularly" irregular" pulse," loss" of" atrial" contractile" function" with" the"
associated" loss"of"active"ventricular" filling,"and" the" risk"of" thromboembolic" stroke." In"addition" to"








Although"drug" therapy" for" rate"control" is"well"established"and"commonly" includes"betaOblockers,"
nonOdihydropyridine" calcium" channel" blockers" and" digoxin," antiOarrhythmic" drug" (AAD)" therapy,"
such"as"class"I"agents"(flecainide"and"propafenone)"and"class"III"agents"(amiodarone"and"sotalol),"to"
reduce"the"burden"of"AF" in" ‘rhythmOcontrol’"strategies,"has"numerous" limitations."First,"AADs"are"
only"able" to"control"AF" in"23O63%"of"patients,"although"this" figure" is" significantly" lower" for" those"
with"more"longerOstanding"AF"and"enlarged"atrial"dimensions."20"21"Second,"their"sideOeffect"profiles"
and"tendency"for"proarrhythmia"are"major"disadvantages."Overall,"the"net"benefit"of"AAD"therapy"
is" modest" at" best." Unsurprisingly," the" suboptimal" efficacy" of" AADs" has" been" one" of" the" main"
motivations" in" the" development" of" nonOpharmacological" approaches" in" the" management" of" AF"
over"the"last"two"decades."" 
1.2!Early!openXheart!surgical!procedures!–!rationale!and!lessons!learnt!
The" surgical" community" must" be" credited" as" the" first" to" apply" the" concepts" of" the" previously"
discussed" ‘multiple"wavelet"hypothesis’" therapeutically." The" first"of" these"was" the"description"of"
the" ‘corridor’" procedure" by" Guiraudon" in" 1985." 22" The" procedure" entailed" isolating" a" strip"
(‘corridor’)" of" atrial" tissue" between" the" two" atria" providing" a" direct" link" between" the" sinoatrial"
node"and"the"atrioventricular"node."The"rationale"of"this"procedure"was"to"reduce"the"critical"mass"
of" atrial" tissue" required" to" sustain" the" multiple" reOentrant" wavelets" implicated" in" AF." The"
procedural" results,"with" respect" to" freedom"from"AF"were" respectable,"but" there"was"one"major"
limitation" to" this" technique."Although" the" ‘corridor’"was" free" from"AF" and"permitted" sinus" node"











The" late" 1980s" saw" further" surgical" research" involving" experimentation" with" atrial" incisions" in"
canine" hearts," which" led" the" way" for" Cox" et" al." to" perform" the" first" human" atrial" transection"
procedure"in"1986."Using"a"cut"and"sew"technique"they"were"able"to"restore"sinus"rhythm"(SR)"in"
the" short" term" and"were," therefore," the" first" group" to" demonstrate" that" termination" of" AF"was"
indeed"possible"with" interventional" therapy." 23" The" continued"efforts" of" Cox"et" al.," coupled"with"
their"appreciation"of" the" interOrelationship"between"atrial"anatomy"and"electrophysiology," led" to"








of" conduction" between" the" SAN" and" the" AVN," which" was" similar" in" principle" to" Guiraudon’s"
‘corridor’" procedure." Early" iterations" of" the" procedure" were" tainted" by" damage" to" the" intrinsic"
conduction" system" (SAN)," resulting" in" a" high" incidence" of" pacemaker" implantation" as" well" as"
significant"LA"dysfunction."23"The"procedure"underwent"numerous"modifications,"which"culminated"
in" the" CoxOMaze" III" procedure." 24" The" longOterm" followOup" results" were" exceptional," with" SR"
maintained"in"96%"of"patients"beyond"5"years."25""
Unsurprisingly," the" CoxOMaze" III" became" the" gold" standard" for" surgical" ablation" (SA)" for" over" a"
decade," but" there" were" important" caveats" to" consider." The" multiple" atrial" incisions" and"
cardiopulmonary"bypass"ensured"that"the"procedure"remained"long"and"technically"complex"whilst"
retaining" a" significant" risk" of"morbidity." Thus," although"highly" effective," the" ‘CoxOMaze’" failed" to"
gain" popularity" as" a" treatment" modality" for" standalone" AF," and" became" reserved" for" those"



















work" by" Haissaguerre" et" al." in" 1998." 13" They" were" the" first" to" describe" that" PV" ectopic" foci,"
witnessed" during" invasive" electrophysiological" studies," were" the" triggers" of" AF" in" a" significant"
proportion" of" patients." This" finding" provided" the" necessary" impetus" for" electrophysiologists" to"













in"all"patients." 29O31" It" stands" to" reason" that"PVI"will"be"of"most"benefit" in"paroxysmal"patients" in"
whom" PV" triggers" predominate" as" the" main" mechanism." However," those" with" more" persistent"
forms" of" AF," where" time" has" disrupted" the" electroOanatomical" architecture" of" the" atria," require"
more"than"just"PVI."Put"another"way,"if"the"atria"are"already"in"a"state"of"persistent"fibrillation"(with"
the"substrate"alone"maintaining"fibrillation)"the"importance"of"PV"triggers"becomes"less"important,"





lesions" to" interrupt" the" macroOreOentrant" loops" that" contribute" to" the" maintenance" of" AF."
Commonly"used"linear"lesions"include"a"roof"line"connecting"the"left"and"right"superior"PVs,"and"a"





undertaken," the" aim" must" be" to" achieve" and" confirm" biOdirectional" block" to" document" the"
completeness"of"such"lines."Furthermore,"it"is"best"not"to"attempt"linear"lines"than"to"leave"them"
incompletely"blocked,"as"this"can"result"in"a"highly"proOarrhythmogenic"atrial"substrate."In"fact"the"
resultant"macroOreOentrant" atrial" tachycardias" (AT)" can" themselves" pose" significant" symptomatic"
burden"to"the"patient."32"
Another" technique" in" lieu" of," or" additional" to," PVI" which" also" modifies" the" substrate" has" been"
investigated"and"advocated"by"Nadamanee"et"al."33"Their"group"targeted"areas"exhibiting"complex"
fractionated" atrial" activity" (CFEs)," thought" to" represent" areas" of" slow" conduction," colliding"














Kaplan4Meier' curves' showing' freedom' from' AF' after' PVI' or' PVI' plus' SM' (substrate' modification' via' linear' lesions);'
p=0.0001.'Reproduced'with'permission.'14!
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Contemporary" CA" can" treat" paroxysmal" AF" with" a" high" degree" of" success" but" results" remain"
suboptimal" for" persistent" and" long" standing" persistent" AF" (LSPAF)," with" patients" often" needing"
multiple"procedures." 39"For"example," in"LSPAF,"previous"studies"show"single"procedure"success"of"
either"27%"at"40"months"or"32%"at" just"over"12"months’"followOup."40"41"Therefore," in"addition"to"
PVI," linear" lesions" and/or" CFE" guided" substrate" modification" are" often" employed" to" improve"
procedural" results" in" this" group." 39" The" stepwise" ablation" approach" has" been" championed" by"
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Haissaguerre’s" group" and" incorporates" PVI," linear" ablation," CFE" targeted" ablation" +/O" right" atrial"
ablation."The"integration"of"these"aforementioned"adjunct"techniques"seems"to"be"a"sensible"and"





With" CA" for" AF" gaining" momentum" in" the" late" 1990s" and" early" 2000s," the" surgical" community"






The"use"of" energy"devices"began"with" the" first" cryomaze"procedures" in" 1999,"where" cryoenergy"
ablation"lesions"completely"replaced"atrial"incisions"(entirely"non"cutOandOsew"Maze"procedure)."44"
This"was" followed" closely" by"Damiano" and" colleagues" pioneering" the" use" of" RF" ablation" devices"
with"the"resultant"development"of"the"CoxOMaze"IV"procedure."45"They"used"a"bipolar"RF"device"to"
create" two" islands" that" isolated" the" PVs" (equivalent" to" wide" area" antral" encirclement)" but"
additional" cryoablation"was" also" employed" to" help" isolate" the"posterior" LA." Instead"of" a"midline"
sternotomy," the" procedure" was" done" via" a" smaller" rightOsided" thoracotomy" but" still" required"







The" evolution" from" the" cutOandOsew" technique" to" energy" delivering" devices" heralded" the" next"
logical"step"O"to"perform"SA"without"a"midline"sternotomy,"on"a"beating"heart." In"fact,"James"Cox"
had"already"set"the"challenge"in"2004,"proclaiming"that"the"ideal"surgical"procedure"for"AF"would"
‘be"performed"via"a"minimally" invasive" incision" (endoscopically"or" robotically),"off"bypass," in" less"
than"1"hour,"with"hospital"discharge"planned"for"the"next"morning’."47"
Thoracoscopic"ablation"has"a"number"of"potential"advantages"when"compared"with"catheterObased"
treatments." The" ability" to" visualise" directly" the" target" tissue" of" the" LAOPVs" junction" improves"
accuracy"of"lesion"delivery"with"less"collateral"tissue"damage"to"surrounding"structures."Lesions"can"
be"visualised" in"real"time,"particularly"with"RF"energy,"and"the"risk"of"PV"stenosis" is"unlikely" if"PV"
lesions"are"placed"correctly"on"the"antrum."The"option"to"excise"the"left"atrial"appendage"(LAA)"is"
also" present," which" can" minimise" subsequent" thromboembolic" risk" and" may" simultaneously"





















appropriate" safety" standards" required" for" AF" ablation." 55O57" The" paucity" of" experience" with"
alternatives"to"bipolar"RF"renders"any"meaningful"comparison"difficult."
In" the" study" presented" in" this" thesis," the" Atricure" RF" surgical" ablation" system" (AtriCure" Inc.,"
Westchester," OH," USA)" was" used" due" to" the" fact" that" there" is" significantly" more" data"
published" using" this" system." However," there" are" two" other" RF" systems" that" are" currently"
commercially"available"and"which"should"be"mentioned."Firstly,"the"COBRA®"Surgical"System"
(San"Ramon,"CA,"USA),"which" is"a"multiOelectrode," temperature"controlled"epicardial"device"
which" is" currently" being" evaluated" in" clinical" trials." The" device" has" a" unique" suction"
mechanism"that"pulls" the"atrial"epicardial" tissue"to" the"probe" in"order" to"obtain"contiguous"
lesions" and" to" maintain" a" stable" position" during" RF" application." Secondly," the" Medtronic"
Cardioablate" systems" (Minneapolis," MN," USA)! which" are" low" profile" RF" ablation" clamps"





rather" than" by" heating." Although" this" can" preserve" myocardial" tissue" architecture" it" takes"
longer" than"RF" to"create" lesions"and"also"has" the"potential" risk"of" thromboembolism"due" if"
intracavity"blood"freezes"as"a"consequence"of"ablation.""
1.4.4!Ganglionated!Plexi!Ablation!
The" intrinsic" cardiac" autonomic" system" comprises" a" complex" weave" of" parasympathetic" and"
sympathetic"nerve"fibres"that"interconnect"the"LA"and"the"PVs."Their"neurones"cluster"in"ganglionic"

































In" 2009," Edgerton" and" colleagues" published" a" further"multiOcentre" series" of" 114" patients"with" a"
mixture"of"AF"classifications"who"underwent"minimally"invasive"PVI,"GP"ablation"and"LAA"excision.""
At" 6"months," SR" rates" off" AAD" were" 71%" for" paroxysmal," 47%" for" persistent" and" 32%" for" long"
standing"persistent"AF"patients."70"
A" number" of" such" studies" were" published" between" 2005" and" 2010," and" it" became" clear" that"
thoracoscopic" PVI" with" or" without" autonomic" denervation" and/or" LAA" exclusion" was" indeed" as"
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effective"as"CA" in" treating"paroxysmal"AF." 16," 65,"71O76"However," the" results" for"persistent"or" LSPAF"
were" suboptimal," but" not" unexpected," given" the" limited" lesion" set" used." The" success" from" the"






majority" still" used" muscle" splitting," miniOthoracotomy" incisions" for" instrumentation." " Although"
clearly"better"than"a"median"sternotomy,"this"remained"too"invasive"from"a"patient’s"perspective."
Efforts" to" reduce" patient" morbidity" and" discomfort," and" to" facilitate" a" faster" postOoperative"
recovery" led" to" the" publication" of" three" reports" between" 2008" and" 2009," detailing" a" totally"
















Later" that" year," Sirak" et" al." published" retrospective" data" on" 32" patients" who" had" undergone" a"
totally"thoracoscopic"approach"to"surgical"AF"ablation."77"Contrary"to"most"surgical"ablation"studies"
performed"up"until"then,"they"conducted"these"procedures"on"persistent"or"LSPAF"patients."Hence,"












Their" lesion"set"was"designed" to" replicate" the"LA" lesions"used" in" the"CoxOMaze" III"procedure"and"
included"a"roof"line"connecting"the"superior"PVs,"a"connecting"line"to"the"base"of"the"resected"LAA,"
and"a"line"connecting"the"roof"line"transversely"with"the"subaortic"root."In"a"more"detailed"fashion"







demonstrating" biOdirectional" block" of" linear" ablation" lines" in" the" nonOparoxysmal" cases." This"
approach"yielded"impressive"results"with"a"single"procedure"success"rate"(defined"as"freedom"from"
atrial"arrhythmias"off"AAD)"of"92%"in"the"paroxysmal"group"and"80%"in"the"nonOparoxysmal"group,"
at"1"year."The"addition"of" robust"electrophysiological" testing"had"clearly" improved"efficacy"when"











and" CA" arms" had" PVI" and" additional" linear" ablation," as" now" expected" in" this" patient" subset."








hope" that" it" would" clarify" the" relative" positions" of" these" two" modalities" in" the" invasive"
treatment" of" AF." One" hundred" and" twenty" four" patients" with" drugOrefractory" AF" were"
randomised" in" a" 2Ocentre" study." In" the"CA" arm" (n=63)," 58.8%"were"paroxysmal"with" 41.2%"
nonOparoxysmal," while" in" the" SA" arm" (n=61)," 73.8%" were" paroxysmal" with" 26.2%" nonO
paroxysmal."The"primary"endpoint"was"freedom"from"LA"arrhythmia"at"12"months,"off"AAD."
36.5%" met" this" endpoint" in" the" CA" group," versus" 65.6%" in" the" SA" group," highlighting" a"
statistically" significant" difference." The" results" are" striking," but" must" be" interpreted" with"
caution,"for"several"reasons."First,"there"were"significant"inequalities"with"regard"to"lesion"set"
depending" on"both"modality" and" site" of" treatment." This"makes" the" comparison"of" the" two"
procedures" difficult." Second," catheter" technology" was" different" between" the" centres," with"
one"using"a"4mm"solidOtip"whilst" the"other"used"a"4mm"irrigatedOtip." Irrigated"tip"catheters"
provide"more"effective"RF" lesions"which"may"have"contribute" to" the" third"point,"which"was"




whether" they" were" paroxysmal" or" persistent" AF" cases" O" inconsistent" with" contemporary"
practice." In" the" SA" group," when" surgical" linear" ablation" was" undertaken," verification" of"
conduction" block" was" not" sought" in" all" of" the" lines," which" may" have" reduced" the" overall"
efficacy" obtained." Finally," major" adverse" events" were" significantly" higher" in" the" SA" group"





In" 2012," Pison" et" al" reported" the" results" of" a" hybrid" ablation" approach" combining" a" totally"
thoracoscopic,"offOpump,"surgical"approach"using"a"bipolar" radiofrequency"clamp"and" linear"
ablation"pen"with"conventional"endocardial"catheter"ablation." 82"Of"the"26"patients"studied,"
11" (42%)"had"persistent"AF"and"11"had"prior"CA" for"AF"or" atrial" flutter" (42%)." The"ablation"
strategy"included"PVI,"posterior"wall"isolation,"mitral"isthmus"line,"cavoOtricuspid"isthmus"line"
and" biOcaval" line." However," not" all" patients" received" all" these" lesions," as" the" strategy" was"










The" high" success" rates" in" this" trial" demonstrate" the" potential" of" this" hybrid" approach,"
however," due" to" the"heterogeneity" of" the" lesion" sets" used," it" is" difficult" to" interpret"which"
lesions"are"required"for"which"subset"of"patients."What"can"be"inferred"is"that"more"advanced"















IV." This" highlighted" the" propensity" of" recurrent" macroOreOentrant" tachycardias" post" openO





an"electrophysiological" study" (EPS)" +/O" ablation" to" all" those"who"had" ‘failed’" having"had" an"
index"procedure"of"PVI" and"GP"ablation" via" a"miniOthoracotomy." 85"Rhythm" recurrence"was"
assessed" rigorously" by" continuous" 1Omonth" transOtelephonic" monitoring" with" AF" triggering"
and" defined" as" supraventricular" tachycardia" of" greater" than" 30" seconds’" duration" in" the"
followOup"period."Of" the"50"patients"enrolled,"20"patients" (40%)"had"recurrent"documented"
AT," of" whom" 13" (65%)" chose" to" undergo" EPS." 14" arrhythmias" were" documented" in" these"
patients" including" AF" in" 8" patients" and" atrial" flutter" in" 3" patients." Importantly," despite"
confirmation" of" acute" entrance" and" exit" block" at" the" index" PVI," the" commonest" finding" in"
those"who"had"recurrent"AF"was"PV"reconnection"(50%"of"PVs)."These"findings"with"regard"to"
PV"reconnection"are"consistent"with"that"of"endocardial"ablation,"which"is"why"it"remains"the"






The" contemporary" management" of" AF" increasingly" includes" the" use" of" interventional"
therapies" such" as" catheter" (CA)" or" surgical" ablation" (SA)." The" 2012" international" consensus"
statement" from" the" Heart" Rhythm" Society," European" Heart" Rhythm" Association," and"
European"Cardiac"Arrhythmia"Society"admits"that"LSPAF"patients"are"the"least"studied"subset"




In" lieu" of" poorly" tolerated" and" ineffective" AAD" therapies," patients" actively" seek" curative"
procedures"in"LSPAF."This"demand"has"driven"electrophysiologists"to"improve"their"outcomes"
to" give" these" patients" a" better" quality" of" life." " Thoracoscopic" SA" has" slowly" evolved" into" a"
potentially"promising"alternative"option"for"patients"who"require"intervention"for"AF."Results"
have"shown"equivalent"success"rates"to"catheter"ablation"for"paroxysmal"AF"and"encouraging"




SA" is" more" likely" to" lie" in" those" with" more" advanced" substrates" where" catheter" ablation"
outcomes"remain"suboptimal.""
This" concept" formed" the" basis" of" the" Catheter" Ablation" versus" Surgical" Ablation" in" Atrial"
Fibrillation" (CASAOAF)" study," which" predated" the" publication" of" the" FAST" and" the" Hybrid"
studies." The" aim"of" CASAOAF"was" to" compare" thoracoscopic" surgical" ablation"with" catheter"

























The" purpose" of" this" study" was" to" investigate" the" hypothesis" that" a" thoracoscopic" surgical"




The" study" was" commenced" in" 2011," having" gained" ethical" approval" from" Oxfordshire"
Research" Ethics" Committee" A," 11/SC/0032." During" the" inception" and" study" design" phase,"
detailed"and"extensive"searches"through"PubMed,"Medline"and"Clinicaltrials.gov"showed"that"
there" were" no" published" trials" comparing" these" two" strategies" headOtoOhead" for" the"
management"of"atrial"fibrillation"(AF),"and"certainly"none"in"the"LSPAF"classification."Of"note,"
there"was" one" randomised" controlled" clinical" trial" identified," ‘Ablation" or" Surgery" for" Atrial"
Fibrillation"Treatment’"(FAST),"ClinicalTrials.gov"Identifier:"NCT00662701,"which"compared"the"
safety" and" efficacy" of" these" two" strategies" in" a" mixed" population" of" AF" patients." This"









endpoints." This" inevitably" led" to" a" degree" of" uncertainty" in" the" understanding" of" the" true"
safety"and"efficacy"of"AF"ablation."We"designed"our"study"carefully"to"try"to"overcome"these"
issues."The"2012"Heart"Rhythm"Society,"European"Heart"Rhythm"Association,"and"European"
Cardiac"Arrhythmia"Society" (2012"HRS/EHRA/ECAS)"consensus"document"sought" to" improve"







Although" published" after" our" study" had" commenced," our" study" design" had" incorporated" a"
number"of"the"aforementioned"recommendations,"which"were"not"only" in"keeping"with"our"
study" rationale," but" also" validated"our" study" design." Furthermore," the" primary" endpoint" of"





























•! Acute" procedural" success" –" defined" as" attaining" SR" at" the" end" of" the" procedure" either"
through"DC"cardioversion"or"termination"to"SR"through"ablation."





The" Royal" Brompton" &" Harefield" NHS" Foundation" Trust" (RB&HFT)" is" one" of" the" largest"
specialist"cardiothoracic"centres"in"Europe,"which"specialises"in"heart"and"lung"transplants"and"
pioneering" minimally" invasive" surgery," including" thoracoscopic" techniques." Despite" this"
wealth"of"thoracoscopic"experience,"thoracoscopic"surgical"AF"ablation"using"radiofrequency"
(RF)"was"still"a"relatively"new"operative"procedure"in"the"trust."The"research"team"were"keen"




choice" to" select" one" of" the" two" interventional" treatments." This" trial" design"was" ratified" by"
RB&HFT" Clinical" Trials"Unit," Imperial" College" London" and" the" research" team."All" individuals"







imaging" (secondary)" endpoints" were" performed" by" blinded" physiologists" and" cardiac"
radiologists"respectively."
The"study"population"was"defined"as"patients"between"the"ages"of"18O80"with"symptomatic,"





The" clinical" success" rates" for" catheter"ablation" in"paroxysmal"AF" (PAF)" are"high,"with" single"
procedure"success"rates"of"67O88%."90"91"Such"procedures"used"to"treat"nonOparoxysmal"AF,"in"
particular"LSPAF,"are"less"encouraging"with"single"procedure"success"rates"of"ranging"from"27O
38%.15"40"92O95" Traditional"open"heart"CoxOMaze"procedures"have"excellent" long" term" results,"
with" one" study" consisting" of" mixed" paroxysmal" (64%)" and" persistent" (36%)" patients"
demonstrating"87.5%"freedom"from"AF"at"a"mean"followOup"of"5.4"±"3"years.25"Due"to"the"high"
success" rates" of" catheter" ablation" in" PAF," openOheart" surgical" ablation" with" its" attendant"
invasiveness"is"understandably"rarely"considered"in"PAF."However,"with"the"advent"of"a"totally"




of" these" aforementioned" points," our" rationale" was" to" investigate" whether" this" alternative"
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totally" thoracoscopic" surgical" ablation" approach" may" provide" superior" single/multiple"
procedural"efficacy,"compared"with"contemporary"catheter"ablation.!
2.3.3!Allocation!of!index!procedure!
Under" normal" clinical" care," patients" recruited" to" the" study" would" have" been" referred" for"
catheter" ablation" of" their" AF," and" hence" theoretically" were" also" suitable" for" thoracoscopic"
surgical"AF"ablation,"barring"specific"contraindications"for"thoracoscopic"surgical"procedures."
Therefore," assignment" of" the" index" procedure" was" based" predominantly" on" patient"
preference." Patients"were" given" the" REC" approved" detailed" patient" information" sheet" (see"
appendix)," and" the" opportunity" to" have" all" questions" answered" by" the" research" team"
(predominantly"the"Chief"Investigator"and"me)"to"help"facilitate"that"choice.""All" information"
given"was" factual"and"was"not"biased"towards"either"procedure," to"enable"the"choice"to"be"
based" entirely" on" patient" preference." All" patients" who" chose" the" surgical" option" were"
discussed"at"an"Electrophysiology"MultiODisciplinary"team"meeting,"consisting"of"at"least"one"



















































2011." Local" institutional" NHS" Research" and" Development" approval" followed" in" June" 2011,"
with"trial"registration"(CASAOAF"Catheter"Ablation"versus"Surgical"Ablation"in"Persistent"Atrial"
Fibrillation)" prior" to" study" initiation" on" ClinicalTrials.gov" (ClinicalTrials.gov" identifier"
NCT01385358)."
2.5.2!Recruitment!
The" primary" recruitment" source" was" the" RB&HFT" outpatient" arrhythmia" clinics," including"
outreach" arrhythmia" clinics" from" nearby" district" general" hospitals." All" patients" who" were"
being" considered" for" catheter" ablation" for" their" LSPAF"were" deemed" as" potentially" eligible"
patients," based" on" a" brief" assessment" of" inclusion" and" exclusion" criteria." After" verbal"
discussion," those" interested" in" participating" in" a" research" study" were" given" the" detailed"
patient"information"sheet"(see"appendix)"which"provided"a"full"account"of"its"nature,"purpose,"
risks,"burdens"and"potential"benefits,"either"as"a"hard"copy"or"electronically"via"email"using"
the" secure" NHS" email" system." Patients" were" asked" to" take" their" time" to" consider" the"
!!
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information," and" contact" the" study" coordinator" if" they"were" keen" to" participate." For" those"
who"did"not"make"contact,"a"followOup"telephone"call"was"made"at"two"weeks."For"potential"
study" subjects," fully" informed" consent" was" obtained" only" after" all" the" aforementioned"
information" had" been" given" and" patients" had" ample" time" to" deliberate" and" further"
opportunity" to" ask" questions." Patients" who" expressed" their" wish" to" participate" at" periods"
shorter"than"24"hours"were"permitted"if"the"patient"felt"that"further"deliberation"would"not"
lead"to"a"change"in"their"decision,"and"that"the"researcher"seeking"consent"was"satisfied"that"
the" patient" had" fully" retained," understood" and" deliberated" on" the" information" given." All"
patients"who"were"keen"to"proceed,"signed"the"ethically"approved"study"consent" form"(see"








All" patients" had" a" thorough" medical" history" taken" and" underwent" clinical" examination,"
transthoracic"echocardiography"and"routine"blood"tests."All"51"patients"had"LSPAF,"with"the"
duration"of"continuous"AF"estimated"from"both"the"history"obtained"from"the"patient"and"the"
records" from" the" referring" cardiologist." If" a" patient" had" undergone" successful" DC"




not" alter" the" classification" of" AF" as" LSPAF" in" accordance" with" the" 2012" HRS/EHRA/ECAS"
consensus" document.26" The" duration" of"continuous"AF" was" defined" as" the" period" of"
continuous"AF" that" led"up" to" the" index"ablation"procedure."The" following" research"baseline"
investigations"(see"below)"were"conducted"prior"to"enrolment"into"the"study."Data"from"the"
baseline" visit" was" entered" into" the" CRF" and" were" then" subsequently" transferred" to" an"
electronic" CRF" (Microsoft" Excel" for" Mac" 2011" spreadsheet)," which" served" as" the" study"




A" 1.5OT" MR" system" with" 32Ochannel" cardiac" coil" (Magnetom" Avanto," Siemens" Healthcare,"




3D"steady" state" free"precession"acquisition"covering" the"whole"heart"was"performed" in" the"
systolic" or" diastolic" rest" period." FirstOpass" gadolinium" angiography" was" also" performed." A"
transaxial"navigator"gated"3D"late"gadolinium"enhancement"dataset"of"the"atria"was"acquired"
15"minutes" after" gadolinium"administration" for" the" assessment"of" atrial" scarring." Sequence"







LA" area" and" length" were" traced" on" the" atrial" systolic" and" atrial" diastolic" frames" of" the"
complete" cine" CMR" (Steady" State" in" Free" Precession," SSFP)" acquired" in" the" left" ventricular"
vertical"and"horizontal" long"axes."LA"maximum"volume"(ventricular"endOsystole)"was"defined"
as" the"phase"with"the" largest"LA"volume"on"visual"assessment"and" just"prior" to"mitral"valve"
opening." LA" minimum" volume" (ventricular" endOdiastole)" as" the" phase" with" the" smallest"
volume/dimension"at"the"point"of"mitral"valve"closure."LA"maximum"and"minimum"volumes"
were"then"calculated"using"the"biplane"areaOlength"method"for"ellipsoid"bodies."LA"emptying"









The" semiOautomated" software" package" (CMR" Tools," Cardiovascular" Imaging" Solutions,"











The"SFO36" is" a"well" validated"36"question" shortOform"health" survey,"which" yields" an"8Oscale"
profile"of" functional"health"and"wellObeing" scores" from" the"patient's"point"of" view.98" It" also"
provides"psychometrically"based"physical"and"mental"health"summary"measures."This"scoring"
system"was" chosen," as" it" is" practical," reliable," and" a" valid"measure" of" physical" and"mental"
health,"which"can"be"completed"in"less"than"ten"minutes."It"is"a"generic"health"measurement"
tool," and" accordingly" has" been" used" in" many" surveys" of" general" and" specific" populations,"
comparing"the"relative"burden"of"diseases,"and"in"differentiating"the"health"benefits"produced"
by" a"wide" range"of" different" treatments."Although" it" has"not" been" specifically" designed" for"






class" I" represents" ‘no" symptoms’," whilst" at" the" other" end" of" the" spectrum" EHRA" class" IV"
represents" ‘disabling" symptoms’" such" that" normal" daily" activity" is" discontinued." In" essence,"
the"higher"the"EHRA"class"the"greater"the"symptoms,"and"the"lower"the"quality"of" life." "This"
scoring"system"only"considers"symptoms"attributable"to"AF"and"importantly"can"be"reversed"












risks," burdens" and"potential" benefits."At" the"baseline" consultation," patients"were" given" the"
opportunity" to"ask"any" further"questions" to"help"aid" their"decision"and"additional" time"was"
given"for"those"who"required"it."""
If" the" patient" chose" catheter" ablation" they" would" be" placed" on" the" waiting" list" with" the"
procedure" scheduled" within" 8" weeks" of" their" baseline" investigations." If" the" patient" chose"
surgical" ablation," they" were" discussed" at" the" Electrophysiology" MultiODisciplinary" Team"
meeting" consisting" of" at" least" 1" electrophysiologist" and"1" cardiothoracic" surgeon" to" ensure"




All" patients"were"already"established"on"oral" anticoagulation"at" the" time"of"enrolment." For"




the" differences" in" anticoagulation" regime" between" the" two" groups" immediately" before"
ablation"detailed"below."
For" those" undergoing" catheter" ablation," procedures" were" performed" on" uninterrupted"
warfarin"with"an"INR"in"the"range"2O3.5."
For"those"in"the"surgical"ablation"arm,"oral"anticoagulation"was"discontinued"5"days"prior"to"
the" scheduled" date" of" ablation" with" patients" receiving" subcutaneous" injections" of" low"
molecular"weight"heparin" (1.5mg/kg)"until"24"hours"prior" to"ablation."Bridging"therapy"with"




radiofrequency" (RF)" catheter" ablation" as" described" in" section" 2.8" with" a" provisional" date"



















and" pulmonary" venous" (PV)" anatomy" and" guide" transOseptal" puncture." Double" transOseptal"
punctures"were"used"to"access"the"LA"via"a"Brockenburgh"needle."Two"long"sheaths"(Preface"
Biosense" Webstar," Diamond" Bar," CA," USA)" were" then" placed" in" the" LA" to" allow" the"






Lowell," MA," USA)" into" the" coronary" sinus" (CS);" quadripolar" catheter" into" the" right" atrial"
appendage"(RAA)"to"allow"the"measurement"of"the"RAA"cycle"length"(CL);"duodecapolar"highO
density"mapping" catheter" AFocus" II" (St" Jude"Medical)" inserted" via" one" of" the" long" sheaths"
initially" to" the" right" atrium" (RA)" and" then" to" the" left" atrium" (LA)" sequentially;" and" finally" a"
3.5mm"irrigatedOtip"DOF"SF"ablation"catheter"(Thermocool,"Biosense"Webster)."
























In" addition" to" the" aforementioned" steps," the" electrophysiological" properties" of" both" atria"
were"examined"immediately"before"and"after"each"step"of"ablation."This"was"achieved"firstly"
by"acquiring"a"CFE"map,"(via"multiple"contact"points"on"the"internal"surface"of"both"atria)"with"




ensued" before" completion" of" PVI," then" PVI" would" be" completed" before" commencing" the"
ablation"treatment"of"the"AT.""
After"restoration"of"SR"(either"by"termination"of"AF"through"ablation,"or"by"DC"cardioversion),"
all" linear" lesions" were" thoroughly" assessed" for" biOdirectional" block." This" was" conducted" by"




and"were" discharged" the" following" day" in" the" absence" of" complications" requiring" a" longer"











The" procedure"was" performed" under" general" anaesthesia"with" doubleOlumen" endotracheal"
tube"tracheal" intubation" for"selective" lung"ventilation."The"entire"procedure"was"performed"
on"the"beating"heart"without"the"use"of"extracorporeal"circulation."A"TOE"was"then"performed"
to"ensure"exclusion"of"thrombus"in"the"LAA"and"LA"and"assess"PV"anatomy."After"appropriate"
positioning" of" the" patient" to" facilitate" thoracoscopic" access," three" thoracoports" were"
introduced" on" the" right" side" (two" 5mm"ports" and" one" 10mm"working" port)" in" a" triangular"
shaped" configuration" appropriate" to" the" patient’s" body" habitus" (Figure" 2.3)." The" right" lung"
was" then" deflated" and" maintained" using" continuous" carbon" dioxide" insufflation" into" the"
pleural" cavity" at" 8O10" mmHg." Using" endoscissors" and" the" endograsper" tools" through" the"
working" ports," dissection" down" to" the" pericardium" was" performed." A" cranioOposterior"
pericardiotomy"was" performed" anteriorly" and" parallel" to" the" phrenic" nerve,"maintaining" at"
least"4O5cm"distance"from"the"phrenic"nerve," to"expose"the"superior" (SVC)"and" inferior"vein"
cavae"(IVC)."To"aid"visualisation,"two"pericardial"retraction"sutures"were"used,"taking"care"not"
to"apply"excessive"tension"to"avoid" inadvertent"phrenic"nerve"damage."Blunt"dissection"was"











PVI" was" then" performed" on" the" right" side" from" the" epicardial" surface" with" the" aid" of" the"
Lumitip" dissector" (AtriCure" Inc.)" and" bipolar" RF" ablation" clamp" (AtriCure" Inc.)" (Figure" 2.4)."
Overlapping"applications"were"deployed"around"each"ipsilateral"pair"of"PVs."RF"is"delivered"in"
bipolar"mode"at"a"frequency"of"460KHz"with"power"output"that"ranges"form"12"to"30"watts."
Using" the" tissue" conductance"measurements" the"Ablation"and"Sensing"Unit" (ASU)" (AtriCure"
Inc.)" (Figure"2.2)"gives"an"audible"and"visual"warning"when"transmurality"has"been"reached.!
PVI"was"then"assessed"using"the"multifunctional"ablation"and"pacing"pen"and"the"Micropace"
OR" lab" intraoperative" testing" unit" (AtriCure" Inc.)" (Figure" 2.2)," initially" to" ascertain" entrance"
block,"and"towards" the"end"of" the"procedure,"upon"restoration"sinus"rhythm," to"assess"exit"
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block" during" pacing," (see" section" 2.9.3)." If" PVI" was" incomplete" upon" initial" entrance" block"
testing,"further"ablation"was"performed"until"PVI"was"achieved."PVI"destroys"the"majority"of"
the" epicardial" ganglionic" plexi" (GP)" located" at" the" PV" antrum." To" locate" any" remaining" GP"
(often" found" at" the" inferior" aspect" of" the" posterior"wall)," highOfrequency" stimulation" (1200"























nerve"and" secondly" the" ligament"of"Marshall" (a"potential" source"of" adrenergic"driven"atrial"
arrhythmias)"was"dissected."After"PVI"of"the"left"sided"PVs,"the"posterior"box"lesion"was"then"
complete." This"marked" the" completion"of" the" set"of" ablation" lesions." If"AF"persisted"at" this"
time" point," external" DC" cardioversion" was" conducted" to" restore" SR" and" allow" for" further"
conduction"block"testing."Sensing"and"pacing"manoeuvres"(see"section"2.9.3)"were"conducted"
using" the" multifunctional" ablation" and" pacing" pen," as" well" as" the" 20" pole" multielectrode"



















LA"GP"are" autonomic" targets" for"AF" ablation,"which"due" to" their" epicardial" location" can"be"
targeted"by"thoracoscopic"surgical"ablation."The"four"major"LA"GP"are"the"superior"left"GP,"the"
inferior" left" GP," the" anterior" right" GP" and" the" inferior" right" GP," which" are" located" within"
epicardial" fat" pads" at" the" border" zones" of" the" PV" antrum." Localisation" of" these" GP" is"










surgical" ablation." " This" was" adhered" to" with" LAA" exclusion" undertaken" after" the" tenth"





using" the" bipolar" RF" ablation" clamp" (AtriCure" Inc.)" a" graph" of" tissue" conductance"
(current/voltage)" versus" time" is" displayed" on" the" ablation" and" sensing" unit" (ASU)" monitor"
(AtriCure"Inc.)"(Figure"2.2)."This"device"produces"and"delivers"RF"energy"in"a"bipolar"mode,"at"a"
frequency"of"approximately"460"kHz,"with"a"maximum"output"power"ranging" from"12"to"30"
Watts." Using" measurements" of" conductance," the" ASU" determines" when" transmurality" has"
been" achieved." Conventional" intraoperative" surgical" testing" is" undertaken" using" the"
multifunctional"ablation"and"pacing"pen."The"pen" is"placed"sequentially"on"the"superior"and"
inferior" PVs" after" lesions" have" been"delivered" using" the" bipolar" RF" ablation" clamp" to" show"
entrance"block."The"pen"is"then"used"to"pace"the"PV"side"of"the"PVI"lesions"to"ensure"the"atrial"
body" does" not" capture," which" confirms" exit" block." For" the" success" of" the" procedure," it" is"
essential" to" assess" and" confirm" biOdirectional" conduction" block" of" all" ablation" lines." If"








Diagnostic" Catheter)," designed" primarily" for" percutaneous" endocardial" electrophysiological"
mapping" and" the" EnSite" VelocityTM" system" threeOdimensional" cardiac" mapping" system" (St"
Jude"Medical)."The"multielectrode"catheter"is"introduced"through"one"of"the"ports,"visualised"
by" the" camera" and"positioned"using" standard" thoracoscopic" instruments." The" catheter"was"
then"connected"to"the"EnSite"VelocityTM"system"for"recording"of"electrograms."The"catheter"
was"wrapped" around" the" entire" circumference" of" each" of" the" ipsilateral" pairs" of" veins" and"
used"to"map"the"PVs"at"multiple"locations"to"provide"detailed"confirmation"of"entrance"block,"


















AAD" therapy," defined" as" class" I" and" III" AADs," were" discontinued" at" the" time" of" the" index"
procedure"if"not"already"done."
2.10.2! Blanking!Period!
In" accordance"with" the" 2012"HRS/EHRA/ECAS" consensus" document" there"was" a" 3Omonths’"
‘blanking’"period,"during"which"any"recurrence"of"AF"or"new"onset"of"AT"could"be"treated"by"
DC"cardioversion.26"ATs"after" the" ‘blanking’"period"generally" resulted" in"the"scheduling"of"a"

























any" symptomatic" arrhythmia" episodes" that" were" reported" between" these" followOup" time"






























Due" to" paucity" of" data" with" regards" to" the" primary" endpoint," particularly" with" regards" to!
thoracoscopic"surgical"ablation"outcomes"in"LSPAF"patients,"it"was"difficult"to"perform"robust"
power" calculations." However," an" estimated" single" procedure" success" rate" at" 9"months" for"
surgical" ablation" of" 80%," and" an" estimated" single" procedure" success" rate" at" 9" months" for"







presented" as" the"median" (interquartile" range),"with" comparisons"made" using" the"Wilcoxon"
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Statistical" significance" was" defined" as" p<0.05." Data" were" analysed" using" GraphPad" Prism"




























The" interventional" treatment" of" nonOparoxysmal" (persistent" and" long" standing" persistent)"
atrial"fibrillation"(AF)"remains"one"of"the"most"intriguing"aspects"of"invasive"electrophysiology."
In" addition" to" pulmonary" vein" isolation" (PVI)," these" advanced" atrial" myopathies" require"
additional" substrate" modification," which" in" contemporary" practice" entails" linear" lesions"
and/or"ablation"of"complex"fractionated"electrograms"(CFE)."Despite"extensive"left"atrial"(LA)"




(LSPAF)" and" preserved" left" ventricular" function," as"well" as" to" compare"with" our" previously"
published"data"in"patients"with"persistent"AF"in"heart"failure. 
3.1.2!Methods!
The" patient" enrolment" criteria" comprised" patients" undergoing" first" time" ablation" for" LSPAF"
with" left" ventricular" ejection" fraction" of" at" least" 50%" or" greater." The" catheter" ablation"
procedure"protocol"incorporated"the"acquisition"of"multiple"highOdensity"CFE"maps"including"








The" CFE" area"was" defined" as" the" surface" area" of" CFE" (120ms)" that"was" remote" to" PVI" and"
linear"lesion"ablation"sites"and"all"of"the"data"was"then"analysed"offline."
In" addition," the" biOatrial" CFE" area," AFCL," and" clinical" outcome" data" from" these" nonOheart"
failure"patients"(nonOHF"group)"were"then"compared"with"previously"published"data"in"a"heart"




LA" CFE" area" decreased" post" PVI" (27.6±11.8" to" 21.6±12.5" cm2;" p<0.001);" post" linear" lesions"
(21.6±12.5" to" 16.5±9.8" cm2;" p=0.002);" and" post" CFE" ablation" (16.5±9.8" to" 7.8±8.7" cm2;"




179±42" ms;" p=0.70)." Primary" roof" block" predicted" reduction" in" remote" RA" CFE" area"






RA" surface" areas"were" larger," baseline" and" final" biOatrial" CFE" areas"were" higher," and" there"
were"different"patterns"of"biOatrial"AFCL"prolongation" in"the"nonOHF"group"post"LA"ablation."
The" KaplanOMeier," single" procedure," arrhythmiaOfree" survival" estimation" at" 1" year" was"





passive" bystander" activity." The" fact" that" RF" time" targeting" CFE" ablation" is" an" independent"
predictor"of"clinical"outcome"highlights" the" importance"of" incorporating"CFE"ablation"within"
the" ablation" strategy" for" LSPAF" patients." The" significant" difference" in" clinical" outcome"
between" the" nonOHF" and" HF" groups" may" be" explained" by" important" differences" in" the"
substrate."Firstly,"the"nonOHF"LSPAF"group"had"larger"RA"surface"areas"and"higher"proportions"
of" biOatrial" baseline" and" post" ablation" CFE." Secondly," the" divergent" pattern" in" AFCL"
prolongation"resulting"in"a"RA"to"LA"frequency"gradient,"in"the"nonOHF"group,"implies"that"this"
may"represent"a"more"complex"primary"atrial"myopathy"than"that"when"AF"occurs"secondary"






Contemporary" catheter" ablation"of" paroxysmal"AF" via"wide"area" circumferential" pulmonary"
vein" isolation" (PVI)" is" highly" effective," with" single" procedure" success" rates" of" 67O88%.91"101"
However,"results"for"those"with"nonOparoxysmal"forms"of"AF"remain"suboptimal,"ranging"from"
38O62%"single"procedure"success"off"AAD.39"Although"PVI"is"now"regarded"as"the"cornerstone"
of" all" AF" ablation" procedures," PVI" alone" has" been" demonstrated" to" be" inadequate" with"
regards" to" maintenance" of" sinus" rhythm" in" nonOparoxysmal" AF.15" 90" In" these" patients,"
additional" substrate" modification" is" required" over" and" above" PVI" to" improve" ablation"
outcomes," although" despite" these" additional" ablation" lesions," patients" often" need"multiple"
procedures"to"increase"success"rates.39"Substrate"modification"can"entail"targeted"ablation"of"
CFEs" and" conducting" linear" lesions," both" of" which" have" shown" variable" outcomes" in"
randomised" controlled" studies.39"Areas" of" CFEs" have" been" postulated" to" represent" critical"
regions" that" can"maintain" AF" although" their" exact" significance" remains" debated," and" their"
existence" may" be" heterogeneous" in" origin" (e.g." slow" conduction" zones," pivot" points,"
anisotropy"that"can"facilitate"localised"reOentry).33"62"101"O103"
Previous" studies"have"shown" that" in"mixed"classifications"of"AF" (paroxysmal,"persistent"and"
LSPAF),"PVI"does"reduce"the"amount"of"CFE"both"in"the"vicinity"of"the"PVs"and"at"sites"that"are"
remote" to" PVI.104" 105" It" has" been" postulated" that" this" reduction" in" CFE" represents" either"
passive"CFE"activity"secondary"to"PV"activity"or"the"disruption"of"PV"region"ganglionated"plexi"
(GP)"which"are"known"to"fractionate"AF"electrograms"when"stimulated.104"106"More"recently,"
PVI" and" linear" ablation"has"been" shown" to" reduce" LA"CFE,"whilst"work" from"our" group"has"
shown"reduction"in"biOatrial"CFE"in"persistent"AF"and"heart"failure."107"108"




ablation" +" CFE)," advocated" by" the" Bordeaux" group," seems" to" be" a" reasonable" strategy" to"
adopt"for"nonOparoxysmal"AF.109"It"is"the"predominant"strategy"undertaken"at"our"institution,"














































At" each" of" these" stages" the" AFCL" at" the" right" atrial" appendage" (RAA)" and" the" left" atrial"
appendage"(LAA)"were"recorded"from"bipolar"signals"(averaged"over"10"cycles)"from"catheters"
in"each"respective"appendage.""
To" create" the"CFE"maps," the"mapping" catheter"was" rested" at" a" location"with" good" contact"
with"the"endocardium"(waiting"5"seconds),"to"allow"acquisition"of"multiple"points"from"all"of"
the"bipoles"of" the"mapping"catheter."This"process"was" repeated"until" the"mapping"catheter"
had"been"swept"sequentially"around"the"entire"internal"surface"of"the"chamber."At"any"given"






sampling" period" is" used" routinely" in" our" centre," as" published" data" has" demonstrated" the"
reproducibility" of" data" using" this" time" frame." 110"111" Any" points"which"were" inappropriately"









viii.! CFEOmean" colour"map" set" to" display" CFE" between" 30O120ms"with" areas" of" CFE"




The" catheter" ablation" procedure" is" described" in" detail" in" chapter" 2." In" brief," under" general"
anaesthesia,"transOseptal"access"was"gained"to"permit"LA"access."The"following"catheters"were"
then"placed" in" the"heart:" steerable"decapolar" catheter" (CR"Bard," Lowell,"MA,"USA)" into" the"
coronary"sinus"(CS);"quadripolar"catheter"into"the"RAA"to"allow"the"measurement"of"the"RAA"
cycle"length"(CL);"duodecapolar"highOdensity"mapping"catheter"AFocus"IITM"(St"Jude"Medical)"
inserted" via" one" of" the" long" sheaths" (Preface," Biosense"Webster," Diamond" Bar," CA," USA),"
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The" procedure" commenced" with" the" acquisition" of" baseline" biOatrial" CFE" maps."




Linear" ablation"was" then" conducted" (roof" and"mitral" isthmus)" following"which" a" further" LA"
CFE"map"was" acquired." This"map" represented" the" remaining" CFE" sites" after" PVI" and" linear"
ablation"and," therefore,"was"used" for"directOtargeted"ablation"of"CFEs."The"endpoint"of"CFE"
ablation"was"either"eradication"or"significant"organisation"into"more"stable"electrograms"at"all"
identified" CFE" sites" (with" the" exception" of" the" LAA)." LAA" ablation" was" avoided" to" prevent"
unintentional"electrical"isolation"and/or"perforation"of"this"structure,"but"CFE"located"outside"
the" LAA" at" its" base" were" targeted." After" targeted" LA" CFE" ablation," the" final" phase" of" the"
mapping"protocol"was"undertaken"with" the"acquisition"of" the" final"biOatrial"CFE"map." In" the"
absence" of" AF" termination" to" this" point," DC" electrical" cardioversion" was" then" used" (up" to"











defined" endpoint." Differential" pacing" and" sensing" were" undertaken" from" the" LAA," CS" and"
posterior"wall."If"the"linear"ablation"lines"were"blocked"biOdirectionally"at"this"stage,"they"were"
defined" as" either" primary" roof" or" primary" mitral" isthmus" block." If" linear" lesions" were" not"
blocked," and" additional" ablation" was" undertaken" to" achieve" biOdirectional" block" (e.g."
epicardial"CS"ablation"to"block"mitral"isthmus"line),"then"this"was"defined"as"secondary"block.""
CavoOtricuspid" isthmus" ablation" was" only" conducted" if" there" was" documented" evidence" of"
typical"or"reverse"typical"atrial"flutter"preO"or"intraOprocedurally."This"was"done"whilst"pacing"
the"proximal"CS"with"the"defined"endpoint"being"biOdirectional"block."
If"AF"terminated"to"atrial" tachycardia" (AT)," the"CFE"mapping"and"stepwise"ablation"protocol"
was"terminated,"and"the"AT"mapped"and"ablated"to"SR,"with"confirmation"of"PVI.""
3.3.4.1!Strategy!for!Atrial!Tachycardia!ablation!
The" strategy" used" to" treat" AT" follows" contemporary" techniques." The" first" step" was" to"
ascertain"whether"the"tachycardia"was"focal"in"origin"or"due"to"macro"reOentry."This"was"done"
by"using"a"combination"of"intraOcardiac"recordings"and"the"surface"ECG"P"wave"to"assess"the"
direction"of" its"activation"and" temporal" stability,"using" the"CS"or"LAA"as"a" timing" reference."
Subsequent"assessment"at"the"anterior,"posterior"and"inferior"LA"was"performed"to"ascertain"
whether"macro"reOentry"was"responsible"for"the"arrhythmia."If"a"macro"reOentrant"tachycardia"




sites" encountered" were" LA" roof" dependent," mitral" isthmus" dependent" or" cavoOtricuspid"


























ablation' and'DC' cardioversion' stages' are' shown' in' blue' boxes.'Number' of' AF' termination' is' shown' in' green'
boxes.'Technical'software'failure'resulted' in'the' loss'of'1'baseline,'2'final'RA'maps'and'3'final'LA'maps.'RA'='













ii.! High" frequency" electrical" or" mechanical" artefacts"were"removed."
iii.! The"peakOpeak"voltage/amplitude"threshold"to"detect"CFE"was"adjusted"to"minimise"














The' roof' line'connects' the' left' (LSPV)'and'right'superior'pulmonary'veins' (RSPV)'and'demarcates' the'anterior'









Segmentation' of' the' RA' into' 3' regions:' lateral,' septal' and' appendage.' The' tricuspid' valve' annulus' (TVA)'






To" appreciate" the" remote" effect" of" both" PVI" and" linear" lesions" sets" on" remote" LA" CFE"
accurately," it" was" important" to" ensure" those" areas" circumscribed" by" these" lesion" sets" (to"
within" 5mm" from" PVI" and" linear" lesions)" were" excluded" from" the" analysis" zone." The"
remainder" of" the" geometry" by" default" became" the" LA" denominator" area" i.e." the" LA" CFE"
analysis"zone.""
The" Ensite" VelocityTM" surface"marker" tool" (Figure" 3.4)"was" used" to" delineate" the" following"







iii.! The" sum" total" of" all" regions"within" (i)"with" CFEOmean" ≤120ms," as" denoted"by"whiteO
blue"colour"annotation,"is"defined"the"LA"CFE"area."
 









Posterior' aspect' of' LA' geometry' with' CFE4mean' map.' The' map' shown' is' after' pulmonary' vein' isolation,'





























The"RA"denominator"area"was"defined"by"the" final"RA"map,"acquired" immediately"after" the"
final" LA"CFE"map." This"map"enabled"analysis" of" the" remote"effect"of" all" LA" ablation" lesions"
(PVI," linear," and" direct" targeted" CFE" ablation)" on" the" RA." To" ensure" the" highest" degree" of"
accuracy"and"prevent"confounding"from"LA"ablation"lesions,"all"RA"projecting"lesions"from"the"
LA" (i.e."within" 10mm"of" the" RA" geometry)"were" excluded." As" before," the" Ensite" VelocityTM"
surface"marker" tool" (Figure" 3.4)"was" used" to" delineate" the" following" areas"with" the" Ensite"
VelocityTM"fieldOscaling"algorithm"applied,"and"with"standardised"projection"and"interpolation"
settings"as"defined"previously:"













area" (adding"RF"duration"and"primary" linear" lesion"block" as" explanatory" variables)," and" the"
reduction" of" remote" LA" CFE" area" (by" PVI" and" linear" lesions)." ArrhythmiaOfree" survival" was"
analysed" by" KaplanOMeier" survival" curves" with" logOrank" comparisons" using" the"MantelOCox"







already" been" done." Patients" were" followed" up" in" at" 3," 6," 9" and" 12" months" with" 7Oday"




Arrhythmia" recurrence" was" defined" in" accordance" with" the" 2012" Heart" Rhythm" Society,"








cardioversion," primary" roof" block" was" demonstrated" in" 93%" (28/30)" patients" and" primary"





per" map)" and" 50" RA"maps" (410±161" points" per" map)." The" total" surface" area" included" for"












baseline)" anteriorly," 7.1±5.7" cm2" (6.0±4.5%," p=0.0006)" posteriorly," and" 5.1±3.7" cm2"
(4.5±3.1%," p=1.0)" in" the" LAA." After" addition" of" linear" lesions" and" compared" with" postOPVI"
analysis,"total"LA"CFEOarea"had"further"reduced"to"16.5±9.8"cm2"(14.8±9.5%,"p=0.008"vs."postO
PVI)." This" encompassed" 8.0±5.2" cm2" (7.1±4.9%," p=1.0)" anteriorly," 4.7±3.9" cm2" (4.3±3.7%,"
p=0.03)"posteriorly,"and"3.7±2.9"cm2" (3.4±2.9%,"p=0.27)" in" the"LAA."As"expected,"direct"CFE"
ablation"significantly"reduced"final"LA"CFEOarea,"compared"with"postOlinear"lesion"analysis,"to"

























HF' group' from' this' study' and' the' second' of' the' HF' group' from' our' previously' published' data' allowing' for'





14.7±9.1" cm2" (7.9±4.4%)" laterally," 16.6±9.2" cm2" (9.3±4.8%)" septally," and" 8.6±4.5" cm2"
(4.9±2.3%)" RAA." Final" RA" CFEOarea" after" LA" ablation" was" reduced" to" 24.1±12.9" cm2"
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(13.3±8.1%," p=0.0001" vs." baseline)." This" encompassed" 10.0±6.4" cm2" (5.6±3.5%," p=0.009)"
laterally,"8.9±6.6"cm2" (5.1±3.7%,"p=0.0001)" septally,"and"6.1±4.2"cm2" " (3.6±2.8%,"p=0.02)" in"
the"RAA."(Figure"3.7)."
3.4.2.3! Impact!of!catheter!ablation!on!AF!cycle!length"
LAA" and" RAA"AFCL"were" used" as" the"measure" of" LA" and" RA" AFCL" respectively." LA" AFCL" at"
baseline" was" 153±18" ms." After" PVI," there" was" prolongation" to" 161±23" ms" (p=0.02" vs."
baseline)." LA" AFCL" after" linear" lesions" was" 161±22" ms" (p=1" vs." postOPVI)." LA" AFCL" further"
prolonged" after" LA" CFE" ablation" to" 179±42"ms" (p=0.04" vs." postOlinear" lesions)." RA" AFCL" at"
baseline"was" 163±18"ms." It" increased" after" PVI" to" 171±29"ms" (p=0.25" vs." baseline)." It" was"
167±26"ms" (p=1" vs." postOPVI)" after" linear" ablation," prolonging" to" 168±24"ms" (p=1" vs." postO
linear" lesions)" after" completion" of" LA" CFE" ablation." Hence" in" the" LA," the" AFCL" prolonged"
significantly" after" PVI" and" CFE" ablation," but" was" not" impacted" independently" by" linear"
ablation," whilst" in" the" RA" the" AFCL" was" not" significantly" impacted" upon" by" LA" ablation."
Overall," the"mean" LA" AFCL" prolonged" (153±18" to" 173±29"ms;" p<0.0001)" but" the"mean" RA"
AFCL"did"not"prolong"as"a"result"of"LA"ablation"(163±18"to"168±24"ms;"p=0.26)"resulting"in"a"
final"mean"RA"AFCL" that"was" shorter" than" the" final"mean" LA"AFCL" (168±24" vs." 179±42"ms;"
p=0.70)."
Additional" analysis" of" correlation"between" change" in" LA/RA"AFCL" and" change" in" LA/RA"CFE"







Linear" regression"modelling" was" used" to" determine" predictors" for" baseline" RA" and" LA" CFE"
areas."The"following"explanatory"variables"were"included"in"the"model;"age,"sex,"LA"diameter,"
EF," AFCL" and" AF" duration." In" multivariable" analysis," male" gender" was" the" only" strong" risk"
factor" for"a"higher"baseline"LA"CFE"area" (coefficient"12.7"cm2,"95%"CI"1.9O23.4,"p=0.02)"and"





following" explanatory" variables"were" included" in" the" initial" univariable"model;" age," sex," LA"
diameter,"EF,"AFCL,"AF"duration,"radiofrequency"time,"primary"roof"block"and"primary"mitral"
isthmus" block." " Multivariable" analysis" revealed" that" primary" roof" block" exerted" significant"
influence" in" the" reduction" in" remote" RA" CFE" area" (coefficient" 23.2" cm2," 95%" CI" (3.2O43.2,"




following" independent" explanatory" variables" (age," sex," LA" diameter," EF," AFCL," AF" duration,"
radiofrequency"time)"were"included"in"the"model"for"remote"LA"CFE"reduction"after"PVI,"after"
linear"ablation"(adding"both"primary"roof"and"mitral"isthmus"block"as"explanatory"variables"to"







The" following" independent" explanatory" variables" (age," sex," LA" diameter," EF," AFCL," AF"
duration," radiofrequency" time," primary" roof" and"mitral" isthmus" block," radiofrequency" time"
for"CFE"ablation)"were"included"in"the"model."LA"AFCL"(coefficient"O0.2"cm2,"95%"CI"O0.4O0.01,"
p=0.06)" and" primary" roof" block" (coefficient" O12.2cm2," 95%" CI" O24.8O0.5," p=0.06)" showed" a"
trend" towards" smaller" LA" final"CFE"area" in"univariable"analysis"and" in"multivariable"analysis"
(coefficient" O0.2" cm2," 95%" CI" O0.4O0.03," p=0.09" and" coefficient" O10.3" cm2," 95%" CI" O22.5O1.9,"
p=0.09)"respectively."" 
3.4.2.8!Termination!of!AF!
Termination" of" AF" was" defined" as" termination" to" SR" without" DC" cardioversion," and" was"
observed" in"5"cases." In"2"patients,"direct" termination" to"SR"occurred"at" the"end"of" the" roof"







conducted" incorporating" the" following" explanatory" variables:" age," AF" duration," RF" time,"
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baseline" CL," change" in" AFCL," biOatrial" CFE" area," primary" roof" and"mitral" isthmus" block." " AF"





free" success" rate" at" 300±257" days’" followOup,"was" 40%" (12/30" patients)." The" KaplanOMeier"
arrhythmiaOfree" survival" estimation" 1" year," off" antiarrhythmic" drugs," after" a" single" ablation"
procedure"was"41%"(Figure"3.8)."
In"the"17"patients"who"had"a"documented"recurrence"of"symptomatic"arrhythmia,"9"had"AF,"5"
had" AT" and" 2" had" both" AF" and" AT." There"were" no" deaths" during" followOup," although" one"
patient" had" a" primary" intraOcerebral" event" in" the" context" of" a" supraOtherapeutic" INR" level"
within" the" 3" months’" blanking" period," with" a" recurrence" of" documented" AF" whilst" an" inO
patient."Due"to"the"residual"neurological"deficit,"the"patient"was"unable"to"attend"followOup,"
although" it" had" been" documented" that" the" patient" remained" in" AF" and" was" treated" with"
anticoagulation"and"a"rate"control"strategy. 
3.4.3.1!Predictors!of!clinical!outcome!







total" RF" time" and" total" CFE" RF" time." AF" termination" and" CFE" RF" duration" per" 5"mins"were"
individually"associated"with"a"higher"chance"of"single"procedure"atrial"arrhythmiaOfree"survival"








! HR!(95%!CI)" P!X!VALUE" HR!(95!CI)" P!X!VALUE"
Age/yr" 0.97"(0.92O1.03)" 0.36" " "
Male" 0.75"(0.24O2.37)" 0.62" " "
LA!size/5mm" 0.96"(0.79O1.16)" 0.64" " "
LV!EF/5%" 0.71"(0.34O1.49)" 0.36" " "
AF,!duration/mo" 1.01"(0.95O1.06)" 0.84" " "
Baseline!LA!CFE!area/cm2" 0.99"(0.96O1.04)" 0.88" " "
Baseline!RA!CFE!area/cm2" 1.00"(0.97O1.03)" 0.94" " "
Change!in!LAA!AFCL/5ms" 0.99"(0.86O1.13)" 0.85" " "
Change!in!LA!CFE!area/cm2" 0.98"(0.92O1.04)" 0.46" " "
AF!termination" 0.28"(0.04O2.16)" 0.22" 0.13"(0.01O1.26)" 0.08"
Total!RF,!duration/10!min" 0.87"(0.63O1.21)" 0.41" " "
CFE!RF!duration/5!min" 1.23"(0.93O1.69)" 0.13" 1.57"(1.03O2.40)" 0.04"!!
Key!
HR'='Hazard'Ratio,'CI' =' confidence' interval,' AF' =' atrial' fibrillation,' CFE' =' complex' fractionated' electrogram,' AFCL' ='








The" following" results" compare" this" data" in" nonOHF" patients" with" that" of" our" previously"
published"data" in"persistent"AF"and"heart" failure" (HF)." The"baseline" characteristics"of" these"
two" groups" are" shown" below" (Table" 3.3)." The" LA" size," as" measured" by" LA" diameter" on"
transthoracic"echocardiography"(TTE),"was"smaller,"and"hypertension"was"more"prevalent" in"













Age!(y),!mean!±!SD" 64±9" 66±9" 63±9" 0.09"
Sex!(male),!n!(%)" 48"(80)" 23"(48)" 25"(52)" 0.51"
AF!duration!(months),!mean!±!SD!" 21±16" 19±4" 24±8" 0.28"
LA!size,!mean!±!SD" 44"(7)" 44"(5)" 50"(7)" <0.001"




31"(53)" 21"(72)" 10"(33)" 0.004"
Coronary!artery!disease,!n!(%)" 21"(36)" 9"(31)" 12"(40)" 0.59"
Diabetes!Mellitus,!n!(%)" 8"(14)" 1"(3)" 7"(23)" 0.05"








mins;" p<0.001)," total" RF" time" (58±15" vs." 82±19"mins;" p<0.001," and" PVI" RF" time" (28±10"vs."






In" the" LA" of" the" nonOHF" patients," the" CFE" areas" were" all" higher" than" in" the" HF" group"
respectively." Baseline" total" CFE" area" (27.6±11.8" vs." 18.3±12.0" cm2;" p=0.004)," post" PVI" total"
CFE"area" (21.6±12.5"vs."10.2±7.1"cm2;"p=0.001),"post" LL" total"CFE"area" (16.5±9.8"vs."7.7±6.5"
cm2;"p<0.001),"and"final"total"CFE"area"(7.8±8.7"vs."3.1±3.5"cm2;"p=0.018),""
In" the"RA"of" the"nonOHF"patients," the"baseline" total"CFE"area" (39.8±19.3"vs."25.9±14.1"cm2;"




















Total"procedural"time"(mins)" 271"(±55)" 331"(±55)" 0.001"
Fluoroscopy"time"(mins)" 52"(±16)" 79"(±18)" <0.001"
Total"RF"time"(mins)" 58"(±15)" 82"(±19)" <0.001"
PVI"RF"time"(mins)" 28"(±10)" 46"(±17)" <0.001"
Roof"line"RF"time"(mins)" 3.4"(±1.4)" 3.3"(±1.7)" 0.97"
Mitral"isthmus"line"RF"time"(mins)" 4.9"(±2.4)" 4.0"(±2.4)" 0.16"
CFE"RF"time"(mins)" 9.4"(±7.0)" 12.1"(±7.7)" 0.17"
LA"points"per"map" 475"(±191)" 479"(±99)" 0.92"
RA"points"per"map" 410"(±161)" 373"(±96)" 0.14"
LA"CFE"area"analysis"zone"(cm2)"" 114!(±30)" 117"(±24)" 0.62"
Total"LA"surface"area"(cm2)" 210"(±38)" 213"(±43)" 0.75"
Total"RA"surface"area"(cm2)" 178"(±41)" 136"(±33)" <0.001"
Baseline"(non"PV)"LA"CFE"area"(cm2):" 27.6"(±11.8)" 18.3"(±12.0)" 0.004"
'4'Baseline'anterior'LA'CFE'area'(cm2)' 11.7"(±7.0)" 7.9"(±6.0)" 0.03"
'4'Baseline'posterior'LA'CFE'area'(cm2)' 12.1"(±8.1)" 6.6"(±5.8)" <0.001"
'4'Baseline'LAA'CFE'area'(cm2)' 5.3"(±3.8)" 3.8"(±4.1)" 0.16"
Post"PVI"LA"CFE"area"(cm2):" 21.6"(±12.5)" 10.2"(±7.1)" 0.001"
'4'Post'PVI'anterior'LA'CFE'area'(cm2)' 9.3"(±5.9)" 4.5"(±4.0)" <0.001"
'4'Post'PVI'posterior'LA'CFE'area'(cm2)' 7.1"(±5.7)" 2.8"(±3.2)" 0.006"
'4'Post'PVI'LAA'CFE'area'(cm2)' 5.1"(±3.7)" 2.8"(±2.5)" 0.006"
Post"LL"LA"CFEOarea"(cm2):" 16.5"(±9.8)" 7.7"(±6.5)" <0.001"
'4'Post'LL'anterior'LA'CFE'area'(cm2)' 8.0"(±5.2)" 4.2"(±4.2)" 0.004"
'4'Post'LL'posterior'LA'CFE'area'(cm2)' 4.7"(±3.9)" 1.7"(±2.8)" 0.001"
'4'Post'LL'LAA'CFE'area'(cm2)' 3.7"(±2.9)" 1.7"(±1.8)" 0.002"
Final"LA"CFEOarea"(cm2):" 7.8"(±8.7)" 3.1"(±3.5)" 0.018"
'4'Final'anterior'LA'CFE'area'(cm2)' 2.8"(±3.4)" 1.4"(±2.0)" 0.08"
'4'Final'posterior'LA'CFE'area'(cm2)' 1.7"(±3.5)" 0.2"(±0.9)" 0.06"
'4'Final'LAA'CFE'area'(cm2)' 3.3"(±3.1)" 1.6"(±2.1)" 0.03"
Baseline"RA"CFE"area"(cm2):" 39.8"(±19.3)" 25.9"(±14.1)" 0.002"
'4'Baseline'lateral'RA'CFE'area'(cm2)' 14.7"(±9.1)" 9.6"(±6.8)" 0.002"
'4'Baseline'septal'RA'CFE'area'(cm2)' 16.6"(±9.2)" 10.1"(±7.2)" 0.004"
'4'Baseline'RAA'CFE'area'(cm2)' 8.6"(±4.5)" 6.2"(±5.8)" 0.08"
Final"RA"CFE"area"(cm2):" 24.1"(±12.9)" 12.9"(±11.8)" 0.003"
'4'Final'lateral'RA'CFE'area'(cm2)' 10.0"(±6.4)" 7.0"(±7.1)" 0.14"
'4'Final'septal'RA'CFE'area'(cm2)' 8.9"(±6.6)" 2.5"(±2.8)" 0.0001"






In" terms" of" AFCL," the" pattern" of" prolongation" in" the" LA" was" similar" (AFCL" prolonged"
significantly" after" PVI" and" CFE" ablation," but" there" was" no" impact" from" the" linear" ablation"
lesions)" in" both"NonOHF" and"HF" groups." No" significant" difference"was" seen" at" any" stage" of"
AFCL"measurement"between"the"two"groups"(Table"3.5).""
3.5.3.2!Overall!change!in!AFCL!with!intragroup!analysis!
When" analysing" the" overall" impact" of" LA" ablation" on" biOatrial" AFCL"within" each" group," two"
different" patterns" of" change" emerged" (Table" 3.6)." In" the" HF" group," baseline" LA" AFCL" was"
161±27"which" prolonged" to" 180±42" in" the" final" CFE"map" (p=0.004);" baseline" RA" AFCL"was"
167±33" prolonging" to" 178±40" in" the" final" CFE" map" (p<0.001)." In" contrast," in" the" NonOHF"
group,"the"RA"AFCL"did"not"significantly"prolong"as"a"result"of"LA"ablation"(163±18"to"168±24;"











Baseline!LA!AFCL!! 153±18" 161±28" 0.19"
Post!PVI!LA!AFCL!! 161±23" 170±37" 0.26"
Post!LL!LA!AFCL!! 161±22" 174±34" 0.08"
Final!LA!AFCL! 173±29" 180±42" 0.98"
Baseline!RA!AFCL! 163±18" 167±32" 0.61"
Post!PVI!RA!AFCL! 171±29" 175±33" 0.69"
Post!LL!RA!AFCL!! 167±26" 173±30" 0.41"























AFCL!(MS)" PXVALUE" AFCL!(MS)" PXVALUE"
RA!BASELINE" 163±18" 0.26" 167±32" 0.004"RA!FINAL" 168±24" 178±40"






Non4HF' versus' HF' groups,' single' procedure' Kaplan4Meier' curves' of' atrial' arrhythmia4free' survival' off' AAD'












conflicting" reports" as" to" its" efficacy.95"113"114" In" this" study" the" importance" of" CFE" ablation" is"
clearly" highlighted" by" the" fact" that" the" greater" the" RF" time" targeting" CFE," the" greater" the"
chance"of"clinical"success."This"is"in"keeping"with"a"recent"metanalysis"that"has"shown"greater"
atrial" arrhythmia" free" survival" when" CFE" ablation" is" added" to" PVI" in" nonOparoxysmal"
patients.115"These"observations"suggest"that"CFE"plays"an"important"mechanistic"role"in"these"
patients." The"major" limitation"of"CFE"ablation,"however," is" that"we," as" electrophysiologists,"
lack" the" ability" to" differentiate" between" fractionation" representing" highOfrequency" sources"
that" may" perpetuate" AF" (drivers)" and" those" that" are" passively" activated" (bystander)," for"
example" by" wavefront" collision," during" AF." This" is" demonstrated" by" the" fact" that" PVI" and"
linear"ablation" reduces" the"extent"of"CFE"area"at" sites" remote" from"ablation," shown" in" this"
study"and" in"others,"adding"weight" to" the"hypothesis" that" these"CFE"are" likely" to" represent"
passive" (bystander)" activity." Therefore," an" ablation" strategy" based" solely" on" CFE" ablation"
clearly" cannot" be" justified" until" electrophysiologists" are" able" to" make" this" differentiation"
confidently." This" in" turn" vindicates" the" commonly" used" strategy" of" stepwise" PVI" and" linear"
lesions"followed"by"targeted"CFE"ablation"which"is"supported"by"superior"outcome"data,"but"




and"heart" failure" (HF)" is"noteworthy."Although"the"two"groups"were"not" investigated"at" the"
same"time,"the"catheter"ablation"protocol,"operators,"data"collection"and"analysis"were"very"
similar.""
The" first" observation" is" that" the" pattern" of" findings" with" respect" to" change" in" CFE" is" very"
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similar" in" both" groups." For" example," in" both" HF" and" nonOHF" groups," there" is" sequential"
reduction" in" remote"LA"CFEOarea"post"PVI"and" linear" lesions,"with" the"exception"of" the"LAA"
segment" in" the" nonOHF" group" (Figures" 3.6" and" 3.7)" whilst" in" the" RA," remote" CFEOarea"
reduction"also"occurs"as"a"result"of" isolated"LA"ablation."The"second"observation" is" that" the"
two"groups"exhibit"2"different"patterns"of"AFCL"prolongation"in"response"to"LA"ablation."The"
third"observation"is"the"difference"in"RF"ablation"times"between"the"two"groups."The"fourth"
and"most" striking"difference"between" the" two"groups,"however," is" the"difference" in" clinical"
outcome."The"KaplanOMeier," single"procedure,"arrhythmiaOfree"survival"estimation"at"1"year"
(Figure" 3.8)" is" significantly" lower" in" the" nonOHF" group" (41%" vs." 72%," log" rank" p=0.03)." This"
result" goes" against" the" widely" accepted" notion" that" heart" failure" confers" additional"
complexity" to" the" atrial" substrate" in" AF" rendering" it" more" difficult" to" achieve" SR" through"
catheter"ablation"compared"to"nonOheart"failure"AF.116"
Current" thinking" suggests" the" longer" the" duration" of" AF" and" the" larger" the" LA," the" more"
complex"the"AF"substrate."Furthermore,"it"is"accepted"that"AF"is"driven"predominantly"by"the"





in" their" study"of" chronic"AF"patients,"RA"ablation" terminated"AF" in"26%"of"patients.92"More"
recently,"Narayan"et"al."published"a"novel"computational"mapping"technique,"which"identified"
drivers" of" AF" in" the" form"of" rotors" and" focal" impulses.119" In" a" predominantly" persistent" AF"





cohort"of"persistent"AF"patients,"23%"of"potential"AF"rotors"were" found" in" the"RA.120"These"
and"other"recent"studies"adopt"a"more"pragmatic,"patientOspecific"approach,"targeting"drivers,"
which"are"deemed"to"be"relevant"for"arrhythmia"termination." Intuitively,"this"seems"to"be"a"
sensible" approach," as" it" should" minimise" unnecessary" ablation" whilst" simultaneously"
improving"outcomes.119"121"
In"our"study,"the"nonOHF"LSPAF"group"had"significantly"larger"RA"surface"areas"in"conjunction"
with" higher" RA" CFE" areas" observed" at" both" baseline" and" after" remote" LA" ablation." In" the"
context"of"poorer"outcomes"in"this"group,"this"is"highly"suggestive"of"a"more"advanced"atrial"
substrate" than" the" HF" group." The" other" important" observation" was" the" pattern" of" AFCL"
prolongation." In" the"HF"group" there"was"a"parallel" increase" in" the"AFCL" in" the"LA" (p=0.004)"
and"RA" (p<0.001),"when"comparing"baseline" to" final"CFE"map."This" implies" that" LA"ablation"
had"a"significant" impact"on"the"LA"substrate,"which"in"turn"manifested"in"the"corresponding"
RA"AFCL"changes,"reflecting" its" likely"bystander"role." In"contrast," in"the"nonOHF"group,"there"
was"a"divergent"pattern"of"AFCL" change"with"a" significant" change" in"AFCL" from"baseline" to"
final"CFE"map,"in"only"the"LA"(Table"3.6)."This"resulted"in"a"RA"to"LA"AFCL"frequency"gradient"
at" the" final" biOatrial"map" (after" completion" of" LA" ablation)" indicating" that" the" RA"may"well"
have"been"driving" the"AF" in" a" significant"proportion"of"patients," although" the" small" sample"
size"was"not"powered"to"detect"this"as"a"statistically"significant"difference"(p=0.70)."This"is"in"
keeping" with" data" from" Hocini" et" al.," whose" group" demonstrated" that" in" LSPAF" patients,"
where"LA"ablation"failed"to"terminate"AF"but"resulted"in"an"RA"to"LA"AFCL"frequency"gradient,"
RA"ablation"terminated"AF"in"50%"of"patients.122"One"more"potentially"important"observation"








time)"was"spent"ablating" the"nonOHF"group"compared"with" the"HF"group" in"order" to"obtain"
the"same"endpoints."This"cannot"be"explained"by"a"difference"in"LA"chamber"size"between"the"
two"groups"as"this"was"not"the"case."Plausible"explanations"for"this"observation"are"that"it"was""
easier" to"obtain" the"endpoints" in" the"nonOHF"group"and/or" that" this"may" simply" reflect" the"
increasing"experience"of"the"operators"who"have"become"more"adept"at"conducting"catheter"
ablation."
These"aforementioned"differences" focussing"on" the"RA"are"certainly"plausible"arguments" to"
explain"the"discrepancy"in"outcome"between"the"two"groups."Indeed,"it"emphasises"the"fact"
that" perhaps" more" importance" should" be" given" to" the" biOatrial" aspect" of" the" substrate" in"
LSPAF"patients"whose"primary"atrial"myopathy" (i.e."without" concomitant" left"heart"disease)"
may" well" be" more" severe" and" hence" difficult" to" treat" than" those" with" a" secondary" atrial"
myopathy,"for"example,"secondary"to"HF."It" is"worth"mentioning"at"this"point"the"opinion"of"
the"pioneer"of"cardiac"arrhythmia"surgery,"Professor"James"Cox."He"has"previously"proposed"a"
different" classification" for"AF"based"on"underlying" cause."He"described"primary"AF"as" those"
without" another" cardiac" coOmorbidity" serious" enough" to" warrant" concomitant" surgical"
intervention," and" secondary" AF" as" AF" that" is" due" to" another" left" heart" condition" (e.g."
ischaemia," heart" failure" and" valvular" heart" disease)." " Based" on" surgical" outcomes" he"
postulated" that" primary" nonOparoxysmal" AF" harboured" a" very" abnormal" biOatrial" substrate,"



















The"main" limitation" of" this" study" is" the" small" sample" size," which"may" have" precluded" the"
detection" of" small" but" important" differences" in" parameters" such" as" changes" in" the" AFCL.""
Another"limitation"was"the"fact"that"RA"CFE"maps"were"not"taken"in"parallel"with"the"LA"CFE"
maps"at"all"time"points."The"reason"for"this"was"to"prevent"the"total"procedure"duration"from"
being" too" long" which" could" have" adverse" effects" on" the" patient." In" doing" so" the" stepwise"




With" regards" to" the" second" part" of" the" study" comparing" the" nonOHF" and" HF" cohorts," it" is"
important"to"note"that"these"two"groups"were"studied"at"different"time"points"and"thus"may"
incorporate" unmeasured" differences" to" account" for" the" contrast" in" clinical" outcome."With"
regards"to"the"intensity"of"arrhythmia"followOup,"the"nonOHF"group"presented"in"this"chapter"
had" more" rigorous" followOup," encompassing" 3," 6," 9" and" 12Omonth" 7Oday" ambulatory"
monitoring,"whereas" in" the"previous"HF"group"a"3Omonth"ECG"was" followed"with"a"48"hour"
Holter"monitor"at"6"and"12"months."In"both"groups,"symptomatic"recurrences"also"prompted"
further" investigation." It" is" possible" that" this" discrepancy"may"account" for" the"differences" in"
arrhythmia" free" success," although" it" was" clear" from" the" nonOHF" group" that" patients" with"







and" other" studies," strongly" suggests" that" these" abolished" CFE" represent" passive" bystander"
activity.104"105"108"The"RF"time"spent"ablating"CFE"was"also"an"independent"predictor"of"single"
procedure"arrhythmiaOfree"survival"at"1"year."This"highlights"the"importance"of"incorporating"






to" LA" frequency" gradient"which" implies" a"more" complex"primary" atrial"myopathy" than" that"
which" occurs" when" AF" occurs" secondary" to" HF." The" correct" identification" of" functionally"
important" CFE" drivers," and/or" patients" who"may" benefit" from" additional" RA" ablation,"may"
well"be"the"key"to"improving"clinical"outcomes"in"LSPAF."Further"research"should,"therefore,"









This" work" was" conducted" in" sequence" from" previous" work" published" from" our" group"
investigating"CFE"in"persistent"AF"patients"with"heart"failure"(see"below)."
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and" prevalence" of" atrial" fibrillation" (AF).124" 125" Long" standing" persistent" atrial" fibrillation"







or"catheter"ablation" for"de"novo"LSPAF." Left"and" right"atrial" (LA/RA)"volumes"and"emptying"
fractions" and" left" and" right" ventricular" volumes" and" ejection" fractions" were" measured" at"
baseline," 3" and" 9"months" post" ablation" using" CMR." LA" remodelling" was" defined" as" ≥15" %"





The"mean"duration"of" followOup"was" 267" ±" 16" days." There"was" significant" reduction" in" the"
following"volumes"at"9"months"when"compared"to"baseline:"LAmax"(59.4±14.8"vs."47.9±13.0;"
p<0.001);"minimum"LA"volume"(LAmin)"(49.9±13.2"vs."36.6±12.3;"P<0.001);"and"minimum"RA"
volume" (RAmin)" (63.7±20.9" vs." 45.3±22.7;" p<0.0001)." LA" (16.5±9.2" vs." 25.7" ±12.1;" p=0.001)"
and" RA" (13.1±7.9" vs." 32.6±14.7;" p<0.0001)" emptying" fractions" increased" in" tandem" at" 9"











results" in" LA" (and" RA)" reverse" remodelling" and" improvement" in" biventricular" ejection"








AF" is" the" commonest" arrhythmia" encountered" in" the" general" population." Its" prevalence"
increases"with"age,"from"0.5%"at"40O50"years"to"5O15%"at"80"years."With"an"ageing"population"
worldwide," AF" will" affect" an" increasing" proportion" of" the" population.124" AF" can" cause"




of" interventional" treatments," namely" catheter" ablation," over" the" last" decade" for" the"
treatment"of"patients"with"symptomatic,"drugOrefractory"AF."Pulmonary"vein"isolation"(PVI)"is"
the"cornerstone"of"all" these"procedures,"but"ablation" techniques" for"persistent" forms"of"AF"
often" involve" additional" LA" substrate" modification" in" addition" to" PVI," reflecting" the"
remodelled" atrial" substrate" associated" with" nonOparoxysmal" AF" as" described" above.26" Ten"
randomised"controlled"trials"can"now"be"found"confirming"that"catheter"ablation"is"superior"
to" AADs" with" regards" to" maintenance" of" normal" sinus" rhythm" (SR)." 129O138" Although" the"
majority" of" these" trials" studied" paroxysmal" AF" patients," there" is" one" notable" multicentre"
randomised"control"trial"confirming"the"superiority"of"catheter"ablation"over"medical"therapy"
(70.4%"vs."43.7%,"p=0.002)"in"persistent"AF"over"a"12Omonth"followOup"period.138"
LA" enlargement" has" been" shown" to" be" associated" with" AF" in" many" studies" and" is" also"
associated"with" stroke,"heart" failure"and"an" increased"mortality" risk.139" LA"enlargement"has"
also" been" demonstrated" to" be" an" important" prognostic" predictor" of" success" post" AF"
ablation.140"Furthermore,"there"are"data"to"show"that"postOablation"maintenance"of"SR"allows"
for"atrial"reverse"remodelling"with"significant"LA"volume"reduction,"(using"echocardiography,"
computed" tomography" and" magnetic" resonance" imaging).141O147" LA" volume" is" a" recognised"
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measurement" of" LA" size" and" in" routine" clinical" practice" this" is" commonly" done" by"
echocardiography." The" limitation"with" echocardiographic" techniques" lies"with" the" fact" that"
image" quality" is" operator" dependent," which" in" turn" has" a" bearing" on" the" geometric"
assumptions"that"are"required"to"enable"LA"volume"to"be"calculated."In"contrast,"due"to"the"
high" spatial" and" temporal" resolution" threeOdimensional" reconstructions" that" cardiovascular"




In" general," and" despite" the" technical" and" technological" advances" over" the" last" decade,"
ablation" strategies" to" restore" SR" in" persistent," and" in" particular" LSPAF," have" been"
controversial"in"their"efficacy"and"clinical"benefit,"particularly"in"view"of"the"extensive"ablation"
that" is" often" required." In" these" patients," the" chronicity" of" AF" invariably" leads" to" significant"
electrical" and" structural" remodelling" of" the" atria" through" progressive" dilatation" with" or"
without" accompanying" fibrosis." The" current" paradigm" is" that" the" greater" the" extent" of"
progressive"atrial"dilatation"with"its"consequent"architectural"changes,"the"lower"the"chance"
of"restoration"of"SR"through"ablation." It" is"not"uncommon"for"the"decision"not"to"pursue"an"
interventional" strategy" in" otherwise" symptomatic" patients," to" be" based" on" LA" chamber"
parameters." If" indeed" there" is" the" potential" for" reverse" atrial" remodelling" post" ablation" in"
these"patients,"then"this"may"translate"into"significant"clinical"benefit"to"patients."
The" following" subOstudy"of" the"CASAOAF" trial"was," therefore," designed" to" assess" LA" reverse"
remodelling" and" other" associated" structural" changes" that" may" occur" in" conjunction" with"
reverse" remodelling" in" LSPAF"patients"undergoing"either" catheter"ablation"or" thoracoscopic"










A" 1.5OT" MR" system" with" 32Ochannel" cardiac" coil" (Magnetom" Avanto," Siemens" Healthcare,"
Germany)"was"used" to" scan"48"patients" (mean"age"65±9"years)"with" LSPAF"at"baseline"and"
then"at"3"and"9"months"post"ablation"therapy."Images"of"the"atria"were"acquired"in"the"twoO
chamber" and" fourOchamber" orientation" using" a" breathOhold" ECGOgated" steady" state" free"




LAmax" was" defined" as" the" maximal" LA" volume" just" prior" to" the" mitral" valve" opening"
(ventricular"endOsystole)"with"LAmin"defined"as"the"minimal"LA"volume"at"the"point"of"mitral"
valve" closure" (ventricular" endOdiastole)" (Figure" 4.1)." RA" maximum" volume" (RAmax)" was"
defined"as"the"maximal"RA"volume"just"prior"to"the"tricuspid"valve"opening"(ventricular"endO
systole)"with"RAmin"defined"as"the"minimal"RA"volume"at"the"point"of"tricuspid"valve"closure"
(ventricular" endOdiastole)" (Figure" 4.2)." A" semiOautomated" software" (CMR" Tools,"









the'ostia'of' the'pulmonary'veins.' Longitudinal'diameter'was'measured' in'both'views'and' the'maximum'value'
was'used'for'calculation'of'the'atrial'volumes.'
1
For" LA" volumes" calculation" the" biplane" areaOlength" method" was" used," but" as" the" RA"
morphology"is"complex"this"method"was"not"appropriate."149"150"RA"volumes"were,"therefore,"
measured" from" a" stack" of" contiguous" transaxial" cines" encompassing" the" entire" RA." The" RA"



























Left" and" right" ventricular" volumes" at" endOdiastole" and" endOsystole" were" determined" using"

















The" intraobserver" and" interobserver" variability" of" the" atrial" and" ventricular" indexed"
measurements"was" assessed" in" a" random"sample"of" 10"patients." Two"observers"with"more"
than"3"years"of"CMR"experience"were"employed."To"assess"intraOobserver"variability,"the"same"
observer"measured" atrial" and" ventricular" volumes" from" each" data" set," with" a"minimum" 2O
week" interval" between" repeat" analyses," and" were" blinded" to" the" index" values" for" each"
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parameter" when" repeating" measurements." The" second" independent" blinded" observer"
analysed" atrial" and" ventricular" volumes" to" provide" a" measure" of" interobserver" variability."













LAmax"(ml/m2)" 0.92" 0.0003" O0.55" 8.47" 0.91" 0.0002" O2.26" 5.19"
LAmin"(ml/m2)" 0.90" 0.0008" 0.58" 6.64" 0.90" <0.0001" O2.65" 4.82"
LAEF"(%)" 0.77" 0.01" O1.03" 5.03" 0.65" 0.04" 2.89" 9.81"
RAmax"(ml/m2)" 0.82" 0.006" O2.44" 11.9" 0.75" 0.01" O5.88" 14.35"
RAmin" 0.84" 0.0041" O1.25" 12.26" 0.86" 0.001" O6.6" 8.69"
RAEF"(%)" 0.77" 0.01" O1.09" 10.47" 0.80" 0.005" 3.04" 9.57"
LVEDV"(ml/m2)" 0.95" 0.0001" O0.61" 4.08" 0.87" 0.0009" O15.45" 21.61"
LVESV"(ml/m2)" 0.90" 0.0008" O1.02" 2.73" 0.96" <0.0001" O4.2" 2.4"
LVEF"(%)" 0.90" 0.0008" 0.67" 2.69" 0.90" <0.0001" 1.2" 2.74"
RVEDV"(ml/m2)" 0.96" <0.0001" 2.25" 3.45" 0.76" 0.01" 8.9" 9.67"
RVESV"(ml/m2)" 0.90" 0.0007" O0.28" 4.07" 0.75" 0.01" O6" 6.43"





AntiOarrhythmic" drugs" (class" IC" and" III)" were" stopped" before" or" on" the" day" of" the" ablation"
procedure." The" catheter" ablation" technique" has" been" previously" described" in" detail" (see"
Chapter" 2).151" In" brief," under" general" anaesthesia," using" the" EnSite" VelocityTM" 3D"
electroanatomical"mapping"system"(version"4.0.1/4.0.2,"St"Jude"Medical),"all"four"pulmonary"
veins" (PVs)" were" electrically" isolated," with" additional" substrate"modification" encompassing"
roof" and" mitral" isthmus" linear" lesions" and" ablation" of" complex" fractionated" atrial"
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electrograms." Endocardial" mapping" was" performed" using" a" duodecapolar" highOdensity"




Surgical" ablation" was" performed" using" the" bilateral" video" assisted" thoracoscopic" surgical"
technique" under" general" anesthesia," with" doubleOlumen" endotracheal" tube" placement" for"
selective"lung"ventilation."On"the"right"side,"a"10mm"camera"port"and"two"5mm"working"ports"
were"used"to"allow"opening"of"the"pericardium"with"subsequent"blunt"dissection"to"the"rightO
sided" PVs." Pulmonary" vein" isolation" (PVI)" was" then" conducted" on" the" right" side" from" the"

























Age!(y),!mean!±!SD" 63"±"9" 66"±"8" 60"±"10" 0.03"
Sex!(male),!n!(%)" 29"(69)" 17"(68)" 12"(71)" 0.86"
AF!duration!(months),!median!(IQ!
range)" 22"(16,30)" 23"(15,28)" 18"(16,30)" 0.64"
CVD,!n!(%)" 2"(5)" 2"(12)" 0"(0)" 0.16"""
Hypertension,!n!(%)" 27"(64)" 18"(72)" 9"(53)" 0.21"
Dyslipidaemia,!n!(%)" 9"(21)" 4"(16)" 5"(29)" 0.30"
Diabetes!Mellitus,!n!(%)" 4"(10)" 2"(8)" 2"(12)" 1.00""
Smoking,!n!(%)" 20"(48)" 11"(44)" 9"(53)" 0.57"
CHA2DS2XVASc,!median!(IQ!range)"
range"
2"(1,3)" 3"(1,3)" 1"(0,2)" 0.04"
BetaXblocker,!n!(%)" 34"(81)" 18"(72)" 16"(92)" 0.07"
ACEI!and!/or!ARBs,!n!(%)" 26"(62)" 16"(64)" 10"(59)" 0.74"
Diuretic,!n!(%)" 11"(26)" 9"(36)" 2"(12)" 0.08"
Body!Surface!Area,!mean!±!SD" 2.0"±"0.2" 2.0"±"0.2" 2.0"±"0.1" 0.41"
LAmax!(ml/m2),!mean±!SD" 60"±"15" 65"±"13" 52"±"13" 0.003"
LVEF!(%),!mean±!SD" 59"±"10" 60"±"9" 58"±"10" 0.51"
LVEDV!(ml),!mean±!SD" 60"±"12" 62"±"13" 57"±"8" 0.13"





9"months." 48" patients" underwent" either" surgical" or" catheter" ablation" therapy" successfully,"
achieving"SR"post"procedure."3"patients"subsequently"had"pacemakers"implanted"precluding"








Baseline" data" were" presented" as" number" and" percentage" for" categorical" variables," and"
comparisons" done" using" the" chiOsquared" or" Fisher’s" Exact" Test," while" numeric" data" were"





To" assess" the" change" in" CMR" parameters" between" time" points" in" relation" to" the" effect" of"
remodeller" status," catheter/surgery" and" SR/AF" recurrence," a" series" of" t" tests" or" MannO
Whitney"tests"were"done"with"the"pOvalues"obtained"adjusted"for"multiple"comparisons"using"
the"Bonferroni"correction."
Univariable"and"multivariable" logistic" regression"was"done" to"determine" the"predictors"of"a"
remodeller" and" of" clinical" success" from" ablation." Only" variables" that" had" p" <" 0.25" were"






procedural" success" achieved" in" 97%" (47/48)" of" patients"who"were" in" SR" at" the" end" of" the"
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procedure." Recurrence" of" AF" occurred" in" 27%" (13/48)," and" all" those" patients" underwent"
repeat" ablation," via" catheter" ablation" regardless" of" the" modality" of" index" ablation." Mean"
duration"of"followOup"was"267"±"16"days."
4.4.1!Intraobserver!and!interobserver!variability!
Excellent" intraobserver" agreement" with" a" low" mean" bias" was" seen" for" the" following"




the" rightOsided" values." This" reflects" the" irregularity" of" the" right" heart" anatomy" (shape" and"
trabeculated" regions)" which" limit" both" endocardial" and" epicardial" definition." Furthermore,"
clinicians"are"comparatively" less" familiar"with" the"right"heart"as"compared"to" the" left"heart."
Despite" this," the" intra" and" interOobserver" agreements" remain"excellent" for"both"RV"and"RA"
measurements,"and"are"comparable"to"previous"studies."152"153"
4.4.2!Change!in!atrial!and!ventricular!parameters!at!followXup!
In" the" overall" study" population" (Table" 4.3)," the" absolute" change" (Δ)," as" compared" with"
baseline,"was" significant" in" the" following" parameters:" LAmax;" LAmin;" RAmin;" RAEF;" LVEDV;"
and"RVEF"at"both"the"3"month"and"9"month"time"point."The"change"in"LAEF,"RVEDV"and"LVEF"
















59.4"(±14.8)" 51.0"(±"13.5)" 47.9"(±13.0)" O8.5"(P=0.01)" O3.1"(p=0.92)" O11.5"(P<0.001)"
LAmin!
(ml/m2)"
49.9"(±13.2)" 39.6"(±14.4)" 36.6"(±12.3)" O10.2"(P=0.002)" O3.0"(p=0.92)" O13.3""(P<0.001)"
LAEF!(%)" 16.5"(±9.2)" 22.9"(±12.7)" 25.7"(±12.1)" 6.4"(P=0.03)" 2.8"(p=0.82)" 9.2"(P=0.001)"
RAmax!
(ml/m2)"




























59.1"(±11.9)" 67.1"(±13.7)" 68.6"(±11.7)" 8.0"(P=0.011)" 1.4"(p=1)" 9.4"(P=0.002)"
LVESV!
(ml/m2)"
25.0"(±8.4)" 25.3"(±8.2)" 22.9"(±6.4)" 0.3"(P=1)" O2.4"(p=0.5)" O2.1"(P=0.61)"
LVEF!(%)" 59.2"(±9.7)" 62.8"(±7.8)" 65.5"(±8.8)" 3.6"(p=0.18)" 2.6"(p=0.5)" 6.2"(P=0.003)"
RVEDV!
(ml/m2)"
67.2"(±12.9)" 74.4"(±15.8)" 76.8"(±16.9)" 7.1"(p=0.10)" 2.4"(p=1)" 9.5"(p=0.01)"
RVESV!
(ml/m2)"
31.6"(±9.0)" 30.9"(±9.0)" 33.4"(±10.3)" O0.6"(p=1)" 2.4"(p=0.76)" 1.8"(p=1)"












Over" the" 9" months’" followOup" period," 25/42" (60%)" of" patients" demonstrated" reverse"
remodelling" (remodellers)" whilst" 17/42" (40%)" did" not" reverse" remodel" (nonOremodellers)."
Those" that" remodelled"were"older" [66±8"vs."60±10;"p=0.03],"had"a" larger"LAmax" [65±13"vs."
51±13;"p=0.003],"and"had"a"higher"CHA2DS2OVASc"score"[3(1,3)"vs."1(0,2);"p=0.04]"at"baseline"
when" compared" to" the" nonOremodeller" group" respectively" (Table" 4.2)." There" were" no"
!!
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differences" in" baseline" measures" of" LV" dimensions" and" ejection" fraction" between" the" 2"
groups.!
4.4.4!Remodellers!versus!NonXremodellers!
The" change" in" biatrial" and" biventricular" parameters" between" baseline" and" 9" months" was"
analysed,"and"compared"between"the"two"groups"(Table"4.4).""The""change""in"LAmax""
[O20.9" (±9.9)"vs."1.7" (±7.2);"p<0.0001]"and"LAmin"[O18.6" (±7.5)"vs." O4.4" (±7.7);"p<0.0001]"was"
significantly"greater"in"the"remodeller"group"compared"to"the"nonOremodeller"group"as"would"










































group" at" 9"months," whilst" RAEF" showed" a" trend" towards" improvement" at" 9"months" [26.2"
(18.9," 38.3)" vs." 10" (0.6," 24.2);" p=0.09)." LVEF" increased" in" the" SR" group," but" conversely"




Patients" were" also" analysed" as" per" their" ablation" modality." There" were" no" differences" in"
change"in"any"of"the"parameters"at"any"of"the"time"points"between"the"2"groups"(Table"4.5)."
4.4.7!Atrial!Volume!and!drug!therapy!
Cardiovascular" drugs" such" as" angiotensinOconverting" enzyme" inhibitors" (ACEI)," angiotensin"
receptor" blockers" (ARB)" and" diuretics" can" affect" atrial" remodelling," loading" conditions" and"
atrial" chamber" volume" respectively.154" The" effects" of" these" drugs" were" investigated" by"
analysing"those"treated"and"not"treated"with"these"drugs"throughout"the"study"period,"with"








and" diuretic" therapy" did" not" have" any" significant" impact" in" the" reduction" in" LA" and" RA"
volumes"in"our"population.""
4.4.8!Clinical!predictors!of!LA!reverse!remodelling!and!of!SR!maintenance!
Univariable" and" subsequent" multivariable" logistic" regression" analysis" were" performed" to"
determine"the"clinical"predictors"of"LA"reverse"remodelling."The"results"are"shown"in"Table"4.6"
and"4.7."The"univariable"analysis" showed"age"and"baseline" LAmax" to"be"associated"with" LA"
reverse"remodelling."At"multivariable"analysis,"the"only" independent"predictor"of"LA"reverse"
remodelling"was"baseline"LAmax"[1.08"(1.02O1.16);"p=0.01]."For"clinical"success"of"the"ablation"







! OR!(95%!CI)" p!X!value" OR!(95!CI)" p!X!value"
Age" 1.09"(1.00O1.18)" 0.04" 1.07"(0.96O1.21)" 0.24"
Sex!X!Male" 0.89"(0.23O3.38)" 0.86" " "
AF!duration!(>!24!months)" 1.35"(0.36O5.08)" 0.66" " "
LAmax!" 1.08"(1.03O1.14)" 0.003" 1.08"(1.02O1.16)" 0.01"
Hypertension" 2.29"(0.63O8.32)" 0.21" 1.03"(0.14O7.33)" 0.98"
CHA2DS2XVASc" 5.06"(1.16O22.06)" 0.03" 1.00"(0.51O2.03)" 0.99"
LVEF" 1.02"(0.96O1.09)" 0.50" " "











! OR!(95%!CI)" pXvalue" OR!(95%!CI)" pXvalue"
Age" 0.97"(0.91O1.03)" 0.32" " "
Sex!X!Male" 2.83"(0.82O9.76)" 0.10" 1.76"(0.45O6.90)" 0.42"
AF!duration!(>!24!months)" 0.99"(0.94O1.03)" 0.56" " "
LAmax!" 0.98"(0.94O1.02)" 0.26" " "
RAmax" 0.99"(0.97O1.02)" 0.82" " "
Hypertension!" 0.58"(0.17O2.08)" 0.41" " "
CHA2DS2XVASc" 0.72"(0.49O1.05)" 0.09" 0.74"(0.48O1.13)" 0.16"








results" are" striking," as" they" corroborate" the" previously" observed" phenomenon" of" postO
ablation" LA" reverse" remodelling," seen" predominantly" in" paroxysmal" AF" patients," but" now"
importantly," this"extends" to"LSPAF"patients."This"challenges" the"widely"held"notion"that" the"
progressive"structural"remodelling"that"occurs"in"LSPAF"is"irreversible."Furthermore,"our"data"
shows" that" the" reverse" remodelling" group" had" a" significantly" higher" proportion" of" AF"





be" difficult" to" maintain" SR" longOterm" post" ablation," the" anatomical" changes" that" occur" in"
LSPAF"can"be"reversed"irrespective"of"clinical"outcome."This"may"reflect"the"fact"that"even"in"
patients"with"AF" recurrences," the"overall"net" reduction" in"AF"burden"as"a" result"of"ablation"
facilitates" reverse" remodelling," although" this" study" does" not" specifically" explore" this"









in" LAmax," LAmin" and" RAmin," demonstrating" biatrial" reverse" remodelling" (albeit" more"
pronounced"in"the"LA"volumes"as"both"maximum"and"minimum"volumes"decreased),"as"well"
as" improvement" in" biatrial" emptying" fractions." Importantly," biventricular" ejection" fractions"
also" improved" significantly" between" baseline" and" 9" months," accompanied," somewhat"
counterOintuitively," by" an" increase" in" biventricular" EDV," although" this" increase" may" simply"
reflect" increased" atrial" contribution" to" ventricular" filling," post" ablation." SubOgroup" analysis"





The" lesions"sets" for"both"catheter"and"surgical"ablation"were"extensive," in"keeping"with"the"
challenging"substrate"posed"by"these"LSPAF"patients."Interestingly,"however,"the"modality"of"
ablation"had"no"impact"on"any"of"the"atrial"or"ventricular"parameters"measured."This"suggests"
that" it" is" the" extent," integrity" and" outcome" of" the" ablation" lesions" sets" that" facilitates" the"
cardiac" remodelling," rather" than"whether" the" lesions"were" epicardial" or" endocardial." It" has"
been" previously" postulated" that" LA" volume" reduction" can" be" as" a" consequence" of" post"
ablation" contraction" due" to" scarring," however," this" is" refuted" to" some" extent" by" our" data"
showing" remote" RA" volume" reduction" in" patients" who" have" only" had" LA" ablation.144" As"
previously" mentioned," subgroup" analysis" also" showed" that" LA" reverse" remodelling" is" not"
limited"to"those"with"procedural"success,"but"also"occurs"in"those"who"have"documented"AF"
recurrence.143O145"This" is" likely" to" reflect" the" reduction" in" AF" burden" post" ablation" in" both"




standard" of" cardiac" chamber" volume" and" function" quantification.141O145" Previous" cardiac"
remodelling" studies" have" relied" upon" echocardiography" as" the" predominant" imaging" tool"
used,"and"although"echocardiography"is"commonly"used"in"clinical"practice,"it"has"limitations."
These"include"the"fact"that"image"quality"is"very"operator"dependent"and"often"suboptimal"in"
those" with" poor" acoustic" windows" (e.g." patients" with" raised" body"mass" index" and" chronic"
obstructive"pulmonary"disease)."For"example,"Natale"et"al."have"shown"that"severely"dilated"
LA"in"nonOparoxysmal"AF"exhibit"reverse"remodelling"after"catheter"ablation,"using"simply"LA"




studies" have" shown" that" echocardiography" underestimates" LA" size" as" compared" with"
computed"tomography"and"CMR.156"
Another" advantage" of" CMR" is" the" high" interstudy" reproducibility" due" to" the" fact" it" is" not"
significantly"operator"dependent,"unlike" in"echocardiography."This" is"particularly" relevant" to"
this"study"as"chamber"measurements"were"compared"longitudinally."157"158"
Finally" our" study" has" demonstrated" that" baseline" LAmax" is" an" independent" predictor" of" LA"
reverse" remodelling." The"odds" ratio" (1.08)" suggests" the"higher" the"baseline" LAmax"volume,"
the"more"chance"of"reverse"remodelling,"in"keeping"with"data"from"Fredersdorf"et"al.159"This"
challenges" the" notion" of" irreversibility" of" structural" changes" associated" with" LSPAF," and"




were" conducted" with" patients" in" AF," typical" of" LSPAF" patients." These" patients" were" not"
electrically"cardioverted"immediately"before"CMR"scans"as"these"patients"often"fail"to"restore"
and"maintain"SR"long"enough"to"conduct"these"CMR"scans,"and"because"this"does"not"reflect"
real" world" clinical" practice." Imaging" the" atria" in" AF" is" technically" challenging" and" poses"
challenges"with"regards"to"image"quality."However,"in"addition"to"optimising"ventricular"rate"
control" prior" to" the" scan," technical" adjustments" to" exclude"heart" beats" that" lie" outside" the"
main"average"range"of"ROR"interval"were"used"for"image"acquisition"to"improve"image"quality"















favourable" LA" (and" RA)" reverse" remodelling" and" improvement" in" biventricular" ejection"
fractions."LAmax"volume"at"baseline"is"an"important"predictor"of"LA"reverse"remodelling."This"






Preliminary" results" accepted" as" an" abstract" (poster" presentation)" at" the" ECAS" 9th" Annual"
Congresss,"April"2013,"Paris,"France."















of" longOterm" success" in" AF" ablation." This" has" driven" the" quest" to" improve" the" durability" and"
longevity"of"radiofrequency"(RF)"lesions"and"has"resulted"in"ongoing"advances"in"the"tools"used"by"
electrophysiologists." Recently" a" new" generation" of" catheters" has" emerged" with" inbuilt" contact"
force"(CF)"sensing"technology,"enabling"realOtime"catheter"tipOtoOtissue"CF"analysis"during"ablation."




first" ‘unblinded’"and" then" ‘blinded’." Twenty"patients" in"each"group"underwent"PVI"using"an"
irrigated"tip"catheter"providing"realOtime"analysis"of"catheter"tipOto"tissue"CF."RF"energy"was"
applied"at" 30W"with"a" temperature" limit"of" 48°C." The"operator"was"only"blinded" to" the"CF"
sensor"values"in"the"blinded"group."After"PVI"confirmation,"exit"and"entrance"block"were"reO





Acute"electrical" isolation"was"successfully"achieved" in"all"80"PVs"(100%)" in"each"group"of"20"
patients" (age"62±13"yrs,"26"male)."Baseline"characteristics" (no"statistical"difference)"and"the"
type"of"AF"(35%"paroxysmal,"65%"persistent)"were"well"matched"between"the"two"groups."In"
the" blinded" group," acute" PV" reconnection" rates" were" significantly" higher" than" in" the"
unblinded" group:" 17/80" (21%)" vs." 3/80" (4%);" p=0.001" respectively." Blinding" the" operator"
resulted"in"lower"mean"CF"overall"(11.6g"(10.5,12.9g)"vs."14.4g"(13.3,15.7g);"p=0.002)."Regions"
where"the"CF"applied"was"lower"than"others,"correlated"to"regions"that"were"most"prone"to"
reconnection," i.e." the" ridge"between" the" left" atrial" appendage" (LAA)"and" the" left"upper"PV,"
and"at"the"right"carina.""
5.1.4!Conclusion!
This" prospective," nonOrandomised" clinical" study" demonstrated" that" the" use" of" real" time" CF"
data"during"PVI"significantly"lowers"acute"PV"reconnection"rates."Furthermore,"CF"technology"
identified" low" CF" regions" which" correlated" with" reconnection" areas." The" use" of" this"













contemporary" catheter"ablation"procedures" for"AF,"and"has" rapidly"evolved" into"a" safe"and"
increasingly"efficacious"procedure."26"
However," the" one" crucial" limitation" of" catheter" ablation" is" the" recurrence" of" atrial"
arrhythmias."This"is,"in"part,"related"to"the"recovery"of"conduction"in"previously"ablated"tissue,"
resulting" in" the" electrical" reconnection" of" the" PVs.15" 88" 164" Studies" have" shown" that" acute"
electrical"reconnection"rates"of"PVs"after"PVI"(i.e."within"60"mins),"range"from"33%"to"as"high"
as"93%,"whilst" longerOterm" reconnection" rates" (4"months"postOPVI)"have"been" shown" to"be"
80%.165"166"Furthermore,"there"is"data"to"support"the"hypothesis"that"elimination"of"acute"PV"
reconnections"may"improve"longOterm"success"rates."167"168"Therefore,"strategies"that"seek"to"
create" more" effective" radiofrequency" (RF)" lesions" from" the" outset" (both" transmural" and"
permanent),"are"desirable"in"the"quest"to"improve"both"acute"and"longOterm"success"rates."












be" a" vital" parameter" to" monitor" during" catheter" ablation," but" until" now" it" has" not" been"
possible"to"measure"it"directly.169"170"Historically,"the"CF"has"always"been"gauged"subjectively"
by"the"operator"using"indirect"methods"such"as"tactile"feedback"from"catheter,"XOray"position"
of" the"catheter" tip," and"continuous"monitoring"of" changes" in" intracardiac"electrograms"and"




These" special" catheters" can" measure" the" CF" between" the" catheter" tip" and" the" target"
myocardium" via" a" unique" sensor" located" at" the" distal" tip" of" an" irrigated" RF" catheter"
(ThermoCool®" SmartTouch™," Biosense" Webster," USA)." PreOclinical" data" in" animal" studies"
using"CF" technology"has"demonstrated" that"CF" is" directly" related" to" the" size"of"RF" ablation"
lesions" created," and" that" its" use" can" reduce" the" incidence" of" steam" pops" and" thrombus"
formation," with" subsequent" data" verifying" its" safety" in" humans.170" 172" 173" From" the" clinical"
perspective," real" time" CF" information" has" a" number" of" potential" benefits." It" could" unmask"
known"hotspots"of"poor"catheter"tipOtissue"contact,"allowing"targeted"ablation"at"these"sites"
with"appropriate" levels"of" contact" force" to"produce"durable" transmural" lesions."This" in" turn"
this" could" reduce" rates" of" acute" electrical" reOconnection" and" potentially" improve" clinical"
outcome."This"idea"formed"the"basis"of"this"study.""
The" main" hypothesis" was" that" suboptimal" endocardial" catheter" tip" contact" with" the"
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due" to" undergo" de" novo" AF" ablation" at" our" tertiary" cardiac" centre"were" enrolled" into" this"
prospective" nonOrandomised" study." All" procedures"were" performed" after" obtaining"written"








The" CF" sensing" catheter" used" in" this" study" is" the" SmartTouchTM" catheter" developed" by"
Biosense"Webstar"in"the"USA,"which"is"designed"to"be"fully"integrated"with"its"existing"CARTO"
3" electroanatomical" mapping" system." The" catheter" itself" is" 7.5F" with" a" 3.5mm" externally"






















catheter," the" EZ" Steer" ThermoCool®" Nav," which" was" very" familiar" to" the" operators" in" the"
study" and" importantly" has" very" similar" handling" characteristics." Furthermore," all" of" the"
operators"in"the"study"had"extensive"experience"of"using"the"SmartTouchTM"catheter"prior"to"
commencement"of"the"clinical"trial.""
The" catheter" ablation" procedure" was" performed" on" uninterrupted" warfarin" therapy" in"
accordance" with" 2012" guidelines.26" Transoesophageal" echocardiography" was" undertaken"
immediately" after" induction"of" general" anaesthesia" to"exclude" thrombus" in" the" LAA," assess"
patency" of" the" interatrial" septum," delineate" left" atrial" and" PV" anatomy," and" thereafter" to"
guide" the" transOseptal" puncture" alongside" fluoroscopy" in" order" to" enter" the" left" atrial" (LA)"
chamber." TransOseptal" access"was" then" gained" using" a" Brockenburgh" needle," and" two" long"
sheaths" (Preface"Biosense"Webster,"Diamond"Bar,"CA,"USA)"were"placed" in" the" LA" to"allow"
introduction" of" the" catheters." At" this" point," additional" anticoagulation" in" the" form" of"










system"with"a" twenty"pole" circular"mapping" catheter" (LASSO"2515"NAV,"Biosense"Webster,"
USA)." The" mapping" system" was" able" to" show" the" force" sensor" value" which" reflected" the"
applied"CF"between"the"catheter"tipOtissue"interface"in"real"time."Each"pair"of"ipsilateral"PVs"

















challenge" of" 12mg" given" intravenously" for" each" PV" in" order" to" reveal" any" sites" of"
reconnection." Adenosine" is" used" frequently" in" clinical" practice" to" assess" for" dormant" PV"



















Normally" distributed" continuous" variables" were" presented" as"mean" ±" SD" and" comparisons"
made" using" the" 2Osample" tOtest." Categorical" data" were" presented" as" proportions," and"
comparisons"made"using"the"chiOsquared"test."Skewed"continuous"data"were"presented"as"the"
median"(interquartile"range"(IQR))"and"comparisons"made"using"the"Wilcoxon"rank"sum"test."
To"determine" the"effect"of" several" variables"on"PV" reconnection," generalised" linear"models"
were" used" assuming" gamma"distribution"with" the" logarithm"as" the" link" function." For" these"
analyses," the" ratio" of" the" arithmetic" means" between" pairs" of" groups" was" reported" for"
statistical" significance," full" details" of" which" are" shown" in" Tables" 5.2O5.4." For" clinical"
applicability,"these"ratios,"where"relevant,"are"reported"as"arithmetic"mean"values"in"the"text."


























































































































The" total" procedure" time" in" the" unOblinded" group" compared" with" the" blinded" group" was"





isolated." In" the" unOblinded" group," acute" reconnection" of" 3/80" PVs" (4%)" occurred" in" 3/20"











As" previously" mentioned," the" blinded" group" had" the" greatest" number" of" acute" PV"


















A" comparison" was" then" made" between" the" two" groups" with" regards" to" the" ratios" of" the"
overall"mean"CF"and"overall"mean"total"FTI."This"demonstrated"significant"differences"with"the"
blinded"group"showing"significantly"lower"overall"mean"CF"values"(11.6g"(10.5,12.9g)"vs."14.4g"
(13.3,15.7g);" p=0.002," and" significantly" lower" overall" mean" total" of" FTI" 1819g/s" ((1620,"
2042g/s)" vs." 3055g/s" (2662," 3506g/s);" p<0.0001)," compared" with" those" in" the" unOblinded"
group"respectively.""
At"segmental" level,"analysis"of" the"mean"CF"ratio"between"these"two"groups" (Table"5.2'and'
Figure" 5.7)" showed" that" the" left" anteroOsuperior" (8.7g" (6.8,10.98g)" vs." 12.6g" (10.4,15.4g);"
p=0.02)"and" the" left" superior" (9.5g" (7.7,11.7g)"vs."14.6g" (12.8,16.7);"p=0.001)" segments"had"
significantly" lower"mean"CF"ratio"values" in" the"blinded"group." Interestingly," these"were"also"
the"two"commonest"areas"of"reconnection" in"the" left"PVs,"which"all"occurred" in"the"blinded"
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group." Similarly," on" the" rightOsided" PVs," the" right" carina"which"was" the" commonest" site" of"




















































































































































with" all" other" segments:" left" superior" segment" (9.5g" (7.6," 11.7g)" vs." 11.8g" (13.2,15.8g);"
p=0.04)," left" anteroOsuperior" segment" (8.7g" (6.8,11.0g)" vs." 11.8g" (10.6," 13.3g);" p=0.02)" and"
























































































































































mean"CF" at" segments"which"did"not" experience" reconnection" in" the"unOblinded" group." The"
hypothesis" for" this"analysis"was"based"on" the"assumption" that" segments"may"have"avoided"
reconnection"via"the"availability"and"use"of"real"time"CF"data."Indeed,"the"statistical"analysis"
showed" that" at" the" segments" that" had" a" predilection" for" reconnections," the"mean" CF"was"
significantly"lower"(14.5g"(13.3,15.7g)"vs."19.6"(14.6,"26.3g);"p=0.02)."""
5.4.8!Clinical!predictors!of!reconnection!









































































































(1 ) " The" use" of" real" time" CF" data" during" PVI" resulted" in" very" low" rates" of" acute" PV"
reconnection."Acute"PV"reconnection"rates"were"statistically"much"lower"than"that"observed"
when"the"operator"was"blinded"to"the"CF"data.""
(2)" The" resultant" effect" of" blinding" the" operator" were" that" of" significantly" lower" values" of"
mean"CF"overall."
(3)"Finally,"the"segments"in"the"blinded"group"where"mean"CF"was"significantly"lower"than"at"
other" segments," or" significantly" lower" than" in" the" unOblinded" group," correlated" to" the"
commonest"sites"of"reconnection."
5.5.1!Importance!of!PVs!in!AF!
The" PVs" are" known" to" play" a" critical" role" in" the" pathophysiology" of" AF." PV" ectopics" are"
implicated" in" the" mechanisms" of" both" paroxysmal" and" persistent" AF." Mechanistically," in"
paroxysmal"AF"the"PVs"are"predominantly"a"trigger" for"AF,"whilst" in"persistent" forms" it"may"









PVs." Following" successful" PVI," patients" who" experience" a" recurrence" of" AF" or" atrial"
tachycardia" have" a" very" high" likelihood"of" PV" reconnection,"with" previously" published"data"
documenting" this" figure" to" be" over" 80%.15"88"164"What" is" interesting" is" that" the" converse" is"
found" amongst" patients" who" do" not" experience" a" recurrence" of" atrial" tachyarrhythmia"
following"PVI" i.e." the"rate"of"PV"reconnection"found"on"reOstudying"the"LA" is"much" lower"at"
19O32%." This" is" highly" suggestive" of" the" fact" that" PV" reconnection" plays" an" important"
mechanistic"role"in"these"recurrences."86"177""





there" is" data" supporting" the"aggressive" identification"and" reOisolation"of" acute" reconnected"
PVs"which"translates"into"higher"longOterm"success"rates.167"168"Thus,"technologies"such"as"CF"








the" concept" that" this" is" caused" by" reversible" tissue" oedema,"which" in" itself" is" due" to" poor"
stability" and" contact" between" catheter" tipOmyocardial" tissue" during" ablation.182"183"To" avoid"
the" potential" for" reversibility" of" PV" electrical" isolation," it" is" of" paramount" importance" to"
achieve"optimal"RF" lesions"at" the" first" sitting."This" requires" stable"and"appropriate" levels"of"
contact" force" between" catheter" tipOmyocardial" tissue" to" result" in" permanent" myocardial"
tissue"damage."The"use"of" real" time"CF"data"during"RF"ablation"may" in"part"help"to"achieve"
this"goal.""
The" findings" from" this" study" show" that" significantly" lower" rates" of" PV" reconnection" can" be"
achieved"with" the" use" of" CF" data" during" ablation." Furthermore," areas" of" reconnection" are"
associated"with"lower"CF"values"in"the"blinded"group."These"observations"are"in"keeping"with"







reconnections" in"both"groups"and"it" is" interesting"to"note"that"none"of"the"reconnections" in"











There" are" currently" two" other" tools" available" commercially" to" measure" CF" on" different"
platforms." The" TactiCathTM"Quartz" ablation" catheter" (Endosense," SA)" uses" proprietary" fibre"
optic"sensor"technology"mounted"on"a"3.5mm"open"irrigatedOtip"ablation"catheter,"which"has"
a"75"or"65mm"deflectable"curve."The"CF"measurements"created"by"deformation"of"the"optical"
fibres" in" the" tip"of" the"catheter"are"analysed"on"a"dedicated" separate"workstation,"and" the"
need"for"such"hardware"is"its"main"drawback."The"sensitivity"is"less"than"1g,"which"is"similar"to"
that" of" the" SmartTouchTM" catheter." The" TactiCath" catheter" has" a" wealth" of" clinical" data"
demonstrating"its"safety"and"efficacy"in"human"subjects.173"184"185""
IntelliSense®" (Hansen"Medical" Inc.,"Mount"View"CA,"US),"uses"a" robotic" catheter"navigation"
module,"incorporating"a"systemObased"force"sensing"technology,"and"is"described"in"the"first"
followOon" study" [Section" 5.6]." " It" comprises" an" inner" and" outer" sheath," each" containing" a"
system"of"pull"wires"enabling"deflection"of" the" sheaths."A" conventional" ablation"catheter" is"
passed"through"the"inner"sheath"and"the"Intellisense"CF"system"pulses"the"catheter"proximally"
at"4Hz"and"extrapolates"the"distal"catheter"CF"by"the"resistance"to"catheter"movement."This"
provides" visual" and" vibration" feedbacks" to" the"operator," and" also"has" published"data"of" its"
successful" usage" in" human" paroxysmal" AF.185" 186" The" main" practical" limitation" of" the"
!!
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IntelliSense" technology" is" that" it" can" only" be" used" as" part" of" the" robot" system." The"




values," on" one" screen," is" invaluable" to" the" operator" in" assimilating" lots" of" information" in" a"
timely"manner.""
5.5.6!Limitations!
This" study" has" several" limitations." As" a" nonOrandomised" study" there" may" be" unmeasured"
systematic" differences" between" patient" groups," although" no" differences" were" detected"
between" the" demographics" of" the" two" groups" (Table" 5.1)." There" is" a" theoretical" possibility"
that" during" the" study" the" operators" became" more" adept" at" handling" the" catheter" and" in"
performing"PVI"during"the"initial"unOblinded"phase."If"this"were"the"case,"the"increased"rate"of"
reconnection"observed"when"subsequently"blinded"would"only"underestimate"the"benefits"of"
the" CF" catheter." Furthermore," all" operators" were" very" experienced" and" the" SmartTouchTM"
catheter"was" similar" in"handling" to" a"previous" generation"of" catheter"used"widely"by" these"
electrophysiologists."The"small"sample"size"potentially"limits"the"power"to"detect"differences"
between"groups,"although"statistically"meaningful"differences"were"still"observed"with"these"
small" numbers," suggesting" that" CF" technology" conferred" a" genuine" and" substantial" effect."
Finally,"the"study"was"limited"to"observing"the"impact"of"this"technology"on"shortOterm"acute"





5.6! FollowXon! Study! 1! –! Comparison! of! Robotic! and!Manual! Persistent! AF!
Ablation!using!Contact!Force!!
5.6.1!Introduction!
Following"on" from" this" study,"prospective" registry"data"was" collected"on" the"use"of" robotic"
and" manual" ablation" for" de" novo" persistent" AF" patients" using" CF" technology." The" key"
objective" of" this" study" was" to" compare" remote" robotic" navigation" (RRN)" CF" ablation" with"
Manual" CF" ablation." The" secondary" objective" was" to" compare" the" use" of" CF" with" nonOCF"
ablation"for"both"navigation"modes."!
5.6.2!Methods!
Prospective" registries" of" consecutive" cases" undergoing" de" novo" ablation" for" persistent" AF"
from"six"centres"in"the"UK"and"South"Africa"were"included"for"analysis."The"Royal"Brompton"&"
Harefield"NHS" Foundation" Trust" (RB&HFT)"was"one"of" the" centres" that" contributed"data" to"
this" international"multiOcentre"registry"study."Study"data"from"this"chapter"were" included"as"
was" additional" data" from" the" trust." " In" total" 50" Manual/CF" and" 50" RRN/CF" cases" were"
included." For" the" control" arms," historical" nonOCF" ablation" patients" were" matched" by"
propensity"score"to"give"a"total"patient"cohort"of"200.""In"addition"to"CF"data,"total"procedure"






























5.7! FollowXon! Study! 2! –! Medium! Term! Outcome! for! AF! ablation! using!
Contact!Force!Technology!!
5.7.1!Introduction!
The" index" study"detailed" in" this" chapter" had" shown" that" CF" technology" improved" acute"PV"
isolation"rates."However,"its"impact"upon"longerOterm"clinical"outcome"remains"unknown."The"
key" objective" of" this" study" was" to" assess" the" impact" of" CF" on" freedom" from" atrial"










CF" cases)" were" analysed" of" which" 46%" were" paroxysmal," 36%" persistent," and" 18%" longO
standing"persistent."The"mean"follow"up"duration"was"11.4"±"4.7"months"O"paroxysmal"AF"CF"
11.2"±"4.1"CF"vs."11.3"±"3.9"paroxysmal"AF"nonOCF"(p=0.745)"O"nonOparoxysmal"AF"CF"10.4"±"4.5"
CF" vs." 11.9" ±" 5.4" nonOparoxysmal" AF" nonOCF" (p=0.015)." CF" technology" independently"




0.73" (0.41O1.30);" p=0.289)" in" a" detailed" multivariate" analysis," which" included" duration" of"
followOup." " The" use" of" CF" technology" also" demonstrated" reduced" fluoroscopy" time" in"




superior"medium" term"clinical"outcome" in"only"de"novo"paroxysmal"AF."CF" technology"was"







formation" resulting" in" permanent" myocyte" injury," particularly" in" regions" prone" to"
reconnection"where"operators"would"find"the"real"time"CF"information"invaluable"in"ensuring"
that"good"contact"force"was"achieved." "These"results"may"have" important" implications" if,"as"
previous"studies"have"shown,"reduced"acute"PV"reconnection"translates"into"better"long"term"
clinical"outcomes"for"patients."
The"two"followOon"studies"also"highlight" that"CF"technology"confers" improved"efficacy" in"de"
novo" paroxysmal" cases" as" well" as" when" combined" with" RRN." In" addition," CF" technology"
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The" optimal" interventional" management" strategy" for" those" patients" with" long" standing"
persistent"atrial" fibrillation"(LSPAF)"has"yet"to"be"determined."Catheter"ablation"can"achieve"





more" (on" cardiac" MRI)" were" recruited" and" assigned," according" to" patient" preference," to"
undergo" either" thoracoscopic" surgical" ablation" or" catheter" ablation." The" primary" endpoint"
was"freedom"from"atrial"arrhythmias"after"a"single"procedure"without"antiOarrhythmic"drugs"
(AADs)" within" 9"months" (as" assessed" from" the" end" of" the" 3"months’" blanking" period" to" 9"
months)."Secondary"endpoints"were"clinical"success"(defined"as"75%"or"greater"reduction"of"
AF" burden)," freedom" from" atrial" arrhythmia" after"multiple" procedures," atrial" anatomy" and"







months" were" recruited," with" 26" consecutive" patients" undergoing" thoracoscopic" surgical"
ablation"and"25"consecutive"patients"undergoing"catheter"ablation."The"primary"endpoint"was"
assessed"at"9"months’"followOup."Single"procedure"success"(freedom"from"atrial"arrhythmia)"in"
the" thoracoscopic" surgical" ablation" arm" was" 81%," with" multipleOprocedures" conferring" no"





This" is" the" first" prospective" clinical" trial" comparing" thoracoscopic" surgical" ablation" with"
catheter" ablation" focusing" on" de" novo" LSPAF" patients." It" shows" that" thoracoscopic" surgical"
ablation"can"be"performed"safely"with"superior"single"procedure"efficacy,"but"this"is"tempered"






















unsuitable"as" they"did"not" fit" the"definition"of" LSPAF"as"defined"by" the"2012"Heart"Rhythm"
Society," European" Heart" Rhythm" Association" and" European" Cardiac" Arrhythmia" Society"





required" coronary" artery" bypass" surgery." One" other" patient"was" found" to" have" severe" left"
ventricular" dysfunction" (EF=30%)" and" angina," and" was" excluded" from" the" study" as" per"
exclusion" criteria." 51" patients" underwent" an" ablation" procedure," of" whom" 26" had"













There" was" no" difference" in" baseline" characteristics" between" the" two" groups," except" for"
duration" of" continuous" AF," which" was" greater" in" the" surgical" group" (24" vs." 18" months,"






















































































































































































The" mean" surgical" ablation" procedural" time" was" 242±64" vs." 259±70" mins" in" the" catheter"
ablation" group" (p=0.43)." Acute" procedural" success" was" achieved" in" 22/26" (85%)" surgical"
ablation"patients,"compared"with"24/25"(96%)"of"all"catheter"ablation"patients"(p=0.97)."There"
were"no"procedural"deaths," strokes"or"conversion" to"sternotomy" in" the"surgical"or"catheter"





was" 259±70"minutes" and" fluoroscopy" time"was" 49±17"minutes." Total" RF" ablation" time"was"
54±15"minutes"which" incorporated:"PVI"RF" time"of" 26±10"minutes;" roof"RF" time"of" 208±86"
seconds" (additional" 447±368" seconds" of" roof" RF" ablation" required" in" 2" patients" to" achieve"
bidirectional" block" post" DC" cardioversion);" 290±143" seconds" ablation" at" the"mitral" isthmus"
(additional" 595±508" seconds" in" 16" patients" requiring" additional" ablation" to" achieve"
bidirectional" block" post" DC" cardioversion);" and" 597±384" seconds" of" ablation" of" CFE" in" the"
20/25" (80%)" patients" who" remained" in" AF" after" linear" lesion" deployment." All" 25" (100%)"
patients"had"biOdirectional"block"of"the"LPV,"RPV,"roof"and"mitral"isthmus"lines"at"the"end"of"
the"procedure."
IntraOprocedural" termination"of"AF" (defined"as" termination" to"SR"without"DC"cardioversion)"
occurred"in"6/25"(24%)"patients."In"2"patients,"direct"termination"to"SR"occurred"at"the"end"of"
the" roof" linear" lesion." In" 2" patients," termination" to" SR" occurred" during" directOtargeted" CFE"
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of" these"patients" remaining"atrial"arrhythmia" free"at"9"months"after"a"single"procedure" (off"
AAD)." 
6.4.2.2!Redo!procedure"
The" rigorous" followOup" schedule" followed" the" 3"months’" blanking" period," during" which" 14"
(56%)"patients"had"a" recurrence"of" atrial" arrhythmia,"12"of"whom" (48%)"underwent"a" redo"
catheter"ablation" for" recurrent" symptomatic"atrial"arrhythmias."Of" these"patients,"7"had"AT"
whilst"5"had"AF."Of"the"patients"who"did"not"have"a"redo"procedure,"one"had"had"a"recurrence"
of" AF" but" had" suffered" a" primary" intracerebral" event" at" day" 60" precluding" redo" ablation,"
whilst" the" other" had" a" low" burden" of" minimal" symptomatic" atrial" arrhythmias" (16%" at" 3"
months,"<10%"at"6"months,"<6%"at"9"months"and"<1%"at"12"months,"with"data"derived"from"a"
dual" chamber" pacemaker" implanted" for" sinoOatrial" disease" post" index" ablation)." The"mean"
time" to" occurrence" of" the" first" arrhythmia" in" these" 14" patients" was" 113" (CI" 91O135)" days"
(median"96,"IQR"92O160)." 
6.4.3!Surgical!ablation!
26" patients" chose" to" undergo" surgical" ablation." The" total" surgical" procedure" duration" was"
242±64"mins."The"right"PVs"had"8.3±2.5"clamp"applications"with"a"total"148.0±"61.2"secs"of"RF"
ablation." The" left" PVs" had" 7.8±3.6" clamp" applications" with" a" total" 127.9±56.3" secs" of" RF"
ablation." " Post" PVI" GP"mapping"was" positive" in" 22/26" (85%)" of" patients"with" 14.1±11.2" RF"
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applications," and" a" total" of" 212.5±179.7" secs" of" RF" during" GP" ablation." Post" GP" ablation"
mapping" was" negative" in" 23/26" (88%)" of" patients," with" the" remaining" patient" requiring"
further"RF"at"already"ablated"GP"sites"to"abolish"the"autonomic"response."The"superior"(linear"
lesion)" line" connecting" the" contralateral" superior" PVs" had" 34.3±23.1" RF" applications"with" a"
total" of" 540.8±487.5" secs" of" ablation,"whilst" the" inferior" (linear" lesion)" line" connecting" the"




directly" to" SR" during" superior" line" ablation." Entrance" block" for" both" RPV" and" LPV" was"
demonstrated" in" 24/26" (92%)," and" 20/26" (77%)" patients" had" exit" block" of" the" PVs" and" the"
posterior"wall"box"lesion"demonstrated"post"successful"DC"cardioversion"to"SR."2"patients"did"




‘topOup’" ablation"at"both" superior" and" inferior" line" resulting" in" exit" block"of" the"box" lesion."
Two"further"patients"had"entrance"block"of"both"LPV"and"RPV"(shown"on"surgical"pen"and"EP"
catheter" testing)," but" were" subsequently" refractory" to" DCCV" and" consequently" exit" block"




other" patient" repeatedly" went" into" pacingOinduced" paroxysmal" AT" precluding" exit" block"
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In" order" to" ensure" robust" assessment" of" conduction" block" of" surgical" lesion" sets," both" the"
multifunctional"surgical"ablation"and"pacing"pen"and"the"20"pole"multielectrode"EP"catheter"
was"used"to"test"for"conduction"block"(figure"6.2)."
Due" to" technical" challenges" in" positioning," it" was" not" possible" to" use" the" EP" catheter" for"
entrance" block" testing" for" ipsilateral" PVs" in" 2" patients," and" box" lesion" testing" in" 2" further"
patients." Of" the" 22" patients"who" had" both" surgical" and" EP" catheter" testing" for" conduction"
block," 3" patients" were" found" to" have" PV" connections" on" the" EP" catheter" post" PV" clamp"








































During" the" rigorous" followOup" period," which" followed" the" 3"months’" blanking" period," 5/26"
(19%)" patients" had" a" recurrence" of" atrial" arrhythmias," of" whom" 3/26" (12%)" patients"
underwent"a" redo"catheter"ablation" for" recurrent"symptomatic"AF."One"patient"had"several"
(mildly"symptomatic)"short" runs"of"paroxysmal"AT"and"AF" lasting" less" than"1"minute,"but"as"
the"overall"arrhythmia"burden"was"very"low,"the"patient"was"managed"conservatively"without"
the"addition"of"AADs."Another"patient"had"a"recurrence"of"AF"at"3"months"but"did"not"wish"to"
have" another" interventional" ablation" procedure." In" the" 3" patients" who" had" redo" catheter"
ablation,"all"had"AF"as"recurrence,"and"no"gaps"were"found"in"the"surgical"lesion"set"except"for"







up." Of" the" whole" study" population," only" one" patient" (catheter" ablation" group)" could" not"
attend" for" followOup" due" to" having" a" primary" intracerebral" event" in" the" context" of"
supratherapeutic" INR" levels" within" the" 3" months’" blanking" period" (day" 60)." The" patient"
remained"as"an"inpatient"for"a"number"of"weeks"and"had"documented"recurrence"of"AF"after"
the"blanking"period."Due"to"the"residual"neurological"deficit,"the"patient"was"unable"to"attend"







21/26" (81%)" of" patients" in" surgical" ablation" groups," versus" 11/25" (44%)" patients" in" the"














Surgical' versus' catheter' ablation' single' procedure' Kaplan4Meier' curves' of' atrial' arrhythmia4free' survival' off'






21/26" (81%)" of" patients" in" surgical" ablation" groups" versus" 15/25" (60%)" patients" in" the"
catheter" ablation" group" (p=0.10)." The"mean" number" of" procedures" in" the" surgical" ablation"
group"was"1.04±0.34,"and"1.44±0.51"in"the"catheter"ablation"group.!
The"use"of"AADs"was" limited" to"only"3"patients" in" the"catheter"ablation"arm,"who"had"very"
advanced" substrates" based" on" electrophysiological" findings" at" the" index" catheter" ablation"
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There" were" no" serious" adverse" events" (stroke," MI," emergency" surgery" or" death)" in" either"
group."
6.5.2.4!Major!procedural!complications!
In" the" surgical" group," eight" major" complications" occurred" in" 7/26" patients" (31%)" postO





•! One" patient" had" a" large" rightOsided" pleural" effusion," which" required" admission" for"
drainage"(day"42);"
•! One"patient"had"a"hospitalOacquired"pneumonia"(HAP)"and"also,"in"addition,"significant"














•! One" patient" had" asymptomatic" left" lower" PV" stenosis" (day" 90)," whilst" another" was"
admitted"to"hospital"shortly"after"discharge"with"pulmonary"oedema"(day"2).""
"
Over" the" course" of" the" 9" months’" followOup," the" only" other" adverse" event" to" note" was" a"
primary" intraOcerebral" haemorrhage" in" a" patient" 60" days" post" index" procedure." The" event"
occurred" in" the"context"of" initial"admission"to"hospital"with"unidentified"source"of" infection"
and" supraOtherapeutic" INR." The" atypical" presentation" raised" the" possibility" of" atrioO
oesophageal" fistula" and" this" was" examined" in" detail" by" a" multiOdisciplinary" team" using"






























































































Figure" 6.6" shows" the" change" in" AF" symptom" score" between" 0" and" 9"months." There"was" a"
















The"SFO36"quality"of" life" (QoL)"questionnaires"were"obtained" from"all"51"patients" (100%)"at"




















































































In" the" surgical" group," eight" major" complications" occurred" in" 7/24" patients" (33%)" postO
operatively," compared"with" two"major" complications" in" 2/27" (7%)" patients" in" the" catheter"
ablation"group"(p=0.04)"(see"table"5.2).""2"patients"who"had"chosen"surgical"ablation"had"their"
surgical" intervention" abandoned" at" an" early" stage" in" the" procedure" due" to" anatomical"
abnormalities"leading"to"significant"technical"challenges."The"risk"was"deemed"too"high"for"the"




































and" mortality." The" worldwide" incidence" is" growing" fast" with" data" from" a" recent"











up.40" 41" It" is," therefore," conventional" practice" for" electrophysiologists" to" counsel" patients"
embarking"on"an"interventional"strategy"of"the"likely"success"rates"and"the"potential"need"for"






In" the" late" 1990s," at" around" the" time" of" Haissaguerre’s" seminal" findings" documenting" the"
importance"of"PV"triggers"in"AF,"the"original"cutOandOsew"surgical"CoxOMazeOIII"procedure"was"
already" declining" in" popularity." Although" efficacious," its" highly" invasive" nature," technical"
complexity" and" significant" complication" rates" made" it" increasingly" difficult" to" justify" for"
patients" requiring" stand" alone" intervention" for" AF." However," the" last" decade" has" seen" a"
steady" resurgence" in" surgical" AF" ablation" procedures." Thoracoscopic" surgical" AF" ablation"
(using"a"miniOthoracotomy)"was" first" described" in"2005," followed"by"a" totally" thoracoscopic"
approach"in"2008."72"190"In"late"2012,"the"FAST"study"was"published,"a"landmark"trial,"as"it"was"
the"first"headOtoOhead"study"of"thoracoscopic"surgical"ablation"with"catheter"ablation"albeit"in"




of" the" CASAOAF" study" inception" in" late" 2010," there" had" not" yet" been" a" headOtoOhead"
comparison.77" 78" From" both" electrophysiological" and" patient" perspectives," when" given" the"
choice"between"catheter"and"thoracoscopic"ablation,"those"with"paroxysmal"AF"will"typically"
choose" the" least" invasive" option" when" outcomes" are" equivalent." The" CASAOAF" study"
investigators"felt"that"the"most"logical"(and"justifiable)"group"in"which"to"study"an"alternative"
ablation"strategy"was"patients"with"LSPAF,"who"were"more"likely"to"consider"a"more"invasive"
technique,"particularly" if" it"were" to"provide" improved"single"procedure"outcomes."CASAOAF,"
albeit"nonOrandomised,"was"therefore"designed"to"compare"these"two"modalities"of"ablation"
in"a" thorough"and" robust"manner."Only"de"novo" LSPAF"patients"were" studied," as" too"often"
surgical"ablation"studies"recruit"patients"who"have"previously"failed"catheter"ablation,"which"
confounds" the" true" outcome." The" index" procedure" lesion" sets" were" chosen" to" allow"
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comparison" (as" far"as"possible"given" the"different"approaches)"between" the" two"modalities"
with" patients" following" a" standardised" followOup" schedule" post" index" procedure." Despite"
predating"the"2012"Heart"Rhythm"Society,"European"Heart"Rhythm"Association"and"European"
Cardiac" Arrhythmia" Society" (2012" HRS/EHRA/ECAS)" international" consensus" document" and"







point" of" single" procedure" freedom" from" atrial" arrhythmia" off" AAD" (p=0.007)," although" this"




off" AADs" in" patients" where" the" mean" duration" of" continuous" AF" was" longer" than" in" the"
catheter" ablation" comparator" group" (24" vs." 18" months;" p=0.04)" is" impressive," and"
corroborates"surgical"data"from"Sirak"(retrospective"data)"and"Edgerton"(prospective"data).77"
78" It" is"worth"pointing"out" that" the"one"unifying" theme" in" the" surgical" lesions" sets" in" these"
studies"and"in"CASAOAF"is"the"inclusion"of"thorough"electrophysiological"validation"of"both"PVI"
and" linear"ablation" lesions," consolidating" the"need" for" substrate"modification" in"addition" to"
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a" recurrence," all" of" which" were" AF" only." Of" those," only" three" warranted" redo" catheter"




Second," ganglionated" plexi" ablation"may" have" contributed" to" the" superior" outcome" in" the"
surgical" group." PVI" itself" transects" many" of" the" autonomic" ganglia" located" around" the" PV"
antrum,"but"92%"still"required"additional"targeted"ablation"of"GP"positive"sites"(commonly"at"
the" inferoOpostero"floor"region"close"to"the"coronary"sinus)"with"abolition"of" the"autonomic"
response" attained" in" 100%" of" these" patients.191" The" literature" has" been" controversial" with"
regards"to"GP"ablation,"in"part"because"data"has"shown"the"effects"of"GP"fat"pad"ablation"are"
not" durable,"with" reversal" of" autonomic" denervation" at" 4"weeks.69" A" surgical" review"paper"
from"La"Meir"et"al."questioned"the"value"of"GP"ablation,"as"studies"with"GP"ablation"had"lower"
success"rates"than"those"studies"without,"although"they"warned"that"the"studies"in"question"




should" be" noted" that" the" first" ten" surgical" patients" did" not" have" LAA" exclusion," and" subO
analysis"of"the"surgical"group"with"and"without"LAA"exclusion"showed"no"significant"difference"











LAA" exclusion," whilst" interpretation" of" subgroup" analyses" must" always" be" treated" with"
caution."
Overall," the" rate" of" recurrence" in" the" catheter" ablation" group," and" the" fact" that" surgical"
lesions"were"mostly"intact"in"those"that"required"a"restudy,"provides"compelling"evidence"that"
the" surgical" lesions" were" superior" in" terms" of" durability." Animal" and" clinical" studies" have"
previously" shown" that" that" the" bipolar" radioOfrequency" (RF)" clamp" and" the" linear" ablation"
device"are"able"to"create"robust"transmural" lesions.50O53"These"data"suggest"that"well"placed"
and" validated" surgical" lesions" are" more" durable," contiguous" and" permanent" than" those"




In" the" catheter" ablation" group," when"multiOprocedure" success" is" considered," there"was" an"
increase" in" success" from" 41%" to" 60%." In" the" four" patients" that" had" successful" redo"
procedures," the"mode"of" recurrence"was"symptomatic"AT" (with"one"patient"having"both"AT"
and"AF)."PV"reconnection"was"found"in"all"four"patients,"and"additionally"in"two"of"these,"an"
unblocked" linear" lesion"was" documented." ‘TopOup’" ablation" to" correct" these" reconnections"
and" gaps" led" to" freedom" from" arrhythmia." Once" again," this" highlights" the" shortcomings" of"
index"catheterORF"lesions"in"terms"of"durability."Contact"force"sensing"catheters"were"not"yet"
available" at" the" time"of" this" study," and"hence"were"not" used," but" this" new" technology"has"





catheter" ablation," the" surgical" lesion" sets" were" intact" except" for" one" patient" with" an"
unblocked" superior" line." In" the" two" patients" where" the" surgical" lesions" were" fully" intact,"
despite" extensive" additional" ablation" at" the" second" sitting" (catheter" ablation" redo)," atrial"






It" is" very" important" to" consider" this" aspect" of" the" study’s" success," as" there" is" a" significant"
cohort" of" patients" who," whilst" failing" to" achieve" the" stringent" criterion" of" arrhythmia"
recurrence" (>30" seconds" of" atrial" arrhythmia)," may" still" have" derived" enormous" clinical"






minutes’" duration)," which" increased" the" clinical" success" rate" to" 88%." In" this" study," clinical"
success" was" assessed" with" 3Omonthly" 7Oday" ambulatory" recordings" as" per" the" followOup"






endOpoint" in" all" future" ablation" trials" would" be" a" welcome" development," although" it" does"
commit" patients" to" a" small" implantable" device." The" clinical" success" figures" have" particular"




at"the"cost"of"a"higher"major"complication"rate."This" is" in" line"with"data"from"other"reports,"
including"a" recent" review"paper"which"highlighted" that" the" commonest" complications"were"
related"to"lung"issues,"phrenic"nerve"dysfunction"and"bleeding."81"192"
In" our" cohort," bleeding"was" not" an" issue," but" phrenic" nerve" dysfunction" occurred" in" three"






the"catheter"ablation"group,"3" in" the" surgical"ablation"group)." In"both"catheter"and"surgical"






indeed" antrally" placed," although" there" were" a" few" lesions" within" the" PVI" line" at" sites"
necessary" to" achieve" PVI." It" is" possible" that" either" the" 3D" electroanatomical" map" was"




with" two" possible" reasons" for" this" occurrence" (Figure" 7.1)." First," there" were" anatomical"









and" be" asymptomatic" and" the" prognostic" benefits" of" treatment" in" this" scenario" remain"
unknown.26" In" our" patients," symptoms" were" only" apparent" when" more" than" 1" PV" was"
stenosed," which" is" consistent" with" prior" data" from" other" studies," where" the" authors"
hypothesised" this"may"be"due"to"compensatory" ipsilateral"pulmonary"venous"and"therefore"










Pre4'and'post4ablation'MRI' images'showing'normal'calibre' left'upper'and' lower'pulmonary'veins'pre4ablation,'





lumen" endotracheal" intubation" technique" used" in" thoracoscopic" surgical" procedures" that"
enable" selective" lung" ventilation." PostOoperative" pneumonia" and" atelectasis" are" not"





In" the" catheter" ablation" group," the" only" other" complication" of" note" was" that" of" acute"
pulmonary"oedema"within" 48"hours" of" discharge." This"was" in" the" context" of" preserved" left"
ventricular" systolic" function," and" was" likely" due" to" a" relative" excess" of" intraO" and" periO"





two" groups," there" was" no" significant" difference" between" the"Major" Adverse" Clinical" Event"
(MACE)Ofree"survival"curves"(see"Figure"6.4)"(log"rank,"p=0.19)."This"highlights"the"key"point"of"
using"KaplanOMeier" for"analysis"as" it" focuses"on" the"entire" survival" curve" rather" than"MACE"
events" at" any" oneOtime" point." It" is" debatable" whether" survival" curves" are" of" clinical"
importance"in"this"context."
7.2.2.4!Intraoperative!testing!of!conduction!block!
In" this" study" two" tiers" of" conduction" block" testing" were" employed" for" the" thoracoscopic"
surgical" ablation" group." The" results"were" interesting" in" that" it" showed" that" the" addition" of"
testing" with" the" 20" pole" EP" catheter" for" entrance" block" of" the" PVs" and" the" box" lesion"
increased"the"pick"up"rate"of"acute"nonOisolated"lesions,"as"compared"with"the"multifunctional"







(18/26)" vs." 44%" (11/25);" p=0.06." It" is" clear," therefore," that" if" surgical" testing" alone" is" to"be"
used" in" these"procedures" then"more"testing"at"various"regions"circumferentially"around"the"
PVs"must"be"undertaken"to"ensure"regional"areas"of"PV"conduction"are"identified"and"then"reO
isolated"with" further" RF" clamp" applications." Alternatively,"more" sophisticated" testing" using"
multipolar"EP"catheters"such"as"those"used"in"this"study"may"be"employed,"although"there"are"
inherent" technical" difficulties" in" positioning" these" catheters" to" ensure" full" circumferential"
coverage"around"the"PV"antrum."
7.2.2.5!Quality!of!life!scores!
The"analysis"of"quality"of" life" (QoL)"data" is"of"particular" importance"when"comparing"a"new"
technique" to" an" established" technique." The" increased" complication" rate" in" thoracoscopic"
surgical" ablation"would" intuitively" suggest" that" perhaps"QoL"measures"would" suffer" in" this"
group." However," intragroup" analysis" showed" that" the" surgical" patients" had" significant"
improvement" in" 9/10" QoL" domains" compared" with" baseline" (Figure" 6.10)." In" contrast" the"
catheter"group"showed"significant"improvement"in"only"2/10"QoL"domains."Furthermore,"the"
change" in"QoL"was"significantly"greater" in" the"surgical"group" for"general"health,"vitality"and"
mental"wellObeing."Despite"the"higher"rate"of"complications"in"surgical"ablation"the"net"impact"
on"QoL"was"positive."This" is"an" important"aspect"of"ablation" treatment" that"deserves" to"be"
highlighted,"as"ultimately"the"aim" is" to" improve"patients’"symptoms"and"hence"QoL."The"AF"








The"MRI"subOstudy" is" important"as" it" is" the"first"prospective"study"to"show"that"LA"(and"RA)"




These" findings" challenge" the" notion" that" progressive" structural" remodelling" changes"
associated"with"LSPAF"are"irreversible."Furthermore,"the"baseline"LA"volume"has"been"shown"
to" be" an" independent" predictor" of" LA" reverse" remodelling" with" an" odds" ratio" of" 1.08,"
suggesting" that" the" higher" the" baseline" LAmax" volume," the" more" chance" of" reverse"




outcome" post" ablation," many" patients" with" LSPAF" are" not" offered" interventional" therapy"
based"on"the"fact"their"baseline"LA"size"is"too"large"(often"using"LA"diameter"obtained"from"2D"
MOmode"echocardiography)."41"Perhaps"this" latter"practice"should"change"as"our"data"clearly"








considered" for" ablation," they" will" be" still" be" counselled" to" the" possibility" of" multiple"
procedures"(particularly"with"catheter"ablation),"but"even"if"only"clinical"success"(see"chapter"
6.5.2.2)" is" obtained" this"may" be" enough" for" the" atria" to" reverse" remodel," and" hence" offer"
protection" from" future" arrhythmia" recurrences" and" confer" physiological" advantages" to" the"
patient.""
7.3!CFE!subXstudy""
The" CFE" subOstudy" brings" the" discussion" back" to" the" mechanistic" aspects" of" AF," and" the"
techniques" used" in" catheter" ablation" to" address" these." A" recent" 5" year" outcomes" paper" in"
LSPAF" showed" that" PVI" alone" achieved" long" term" SR" in" only" 24%" patients.31" There" is" now"
overwhelming"evidence"to"show"that"PVI"alone"is"not"sufficient,"and"that"additional"substrate"
modification"is"required,"and"consequently"numerous"adjunct"strategies"have"been"detailed."
These" include" linear" lesions" and" CFE" ablation," both" of" which" have" been" documented" to"
improve"outcomes.195"196"197"The"use"of"linear"ablation"in"catheter"ablation"originally"stemmed"
from" the" highly" efficacious" cutOandOsew" CoxOMaze" procedures," where" a" series" of" linear"
incisions"were"used" to" compartmentalise" and"debulk" the" atria." In" doing" so," it" is" postulated"
that"many"triggers"and"drivers"were"also"eliminated.""CFE"are"thought"to"arise"from"areas"of"
slow"conduction,"functional"conduction"block"or"tissue"anisotropy,"and"may"represent"passive"
bystander" activity" or" drivers" of" AF.33"198" The" elimination" of" CFE" remote" to" sites" of" PVI" and"
linear"lesion"RF"application"has"now"been"documented"in"this"and"other"studies,"including"in"









do" so," and" hence" this" remains" one" of" the"main" limitations" of" employing" CFE" ablation." The"
accurate" identification" of" functionally" important" CFE" would" enable" targeted" ablation" of"
drivers,"which"would"in"theory"improve"outcomes,"reduce"unnecessary"ablation"and"possibly"
reduce"procedure" times."An" exciting" development" in" this" area"has" been" the" computational"
mapping" and" subsequent" ablation" of" drivers," which" has" led" to" impressive" results" in" nonO
paroxysmal"forms"of"AF."This"work"is"in"its"infancy,"but"could"prove"to"be"revolutionary"if"the"
technique"is"reproducible"as"it"would"tailor"the"ablation"procedure"to"concentrate"on"patient"





et" al." in" 1998," there" remains" one" fundamental" limitation," namely" PV" reconnection." This"
limitation"is"once"again"highlighted"by"the"CASAOAF"data,"where"in"all"catheter"ablation"repeat"









sheaths" to" help" maintain" better" contact" between" catheter" tipOtissue;" and" catheter" shaft"
visualisation."However,"these"developments"still"require"the"operator"to"use"a"combination"of"
surrogate" markers" (catheter" stability" on" fluoroscopy," impedance" drop," and" electrogram"




The"CF"study"presented" in"Chapter"5"was"one"of" the" first" to"show"that" this"new"technology"
could"have"a"revolutionary"impact"in"AF"ablation."The"study"demonstrated"that"the"use"of"real"
time"CF"not"only"reduced"acute"PV"reconnections,"but"could"also"minimise"PV"reconnections"
at" known" hotspots" when" using" appropriate" CF." It" also" confirmed" that" if" operators" were"
blinded" to" CF" data," they" would" obtain" insufficient" CF" values" to" prevent" subsequent"
reconnection."More" recent"data" from"another" group"has" shown" that"one"of" the" commonly"
used"surrogates"of"CF,"electrogram"attenuation,"actually"correlates"poorly"with"CF,"although"





superior" to"manual"ablation"without" the"use"of"CF" in"oneOyear"clinical"outcomes,"whilst" the"
second" followOon" study" demonstrated" superior" medium" term" (mean" follow" up" 11.4±4.7"
months)"outcomes" in"paroxysmal"AF.201"202"Both" studies"highlighted"an"additional"benefit" in"
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formation." Conversely," high" CF" values" can" prompt" a" timely" response" from" the" operator" to"
adjust" catheter" orientation" or" pressure" to" reduce" CF," and" potentially" prevent" serious"
complications"such"as"a"steam"pop"or"cardiac"perforation"resulting"in"tamponade.""
This"promising"technology"has"been"heralded"by"some"as"the"missing"link"in"AF"ablation"and"
although" relatively" new," there" is" a" rapidly" growing" evidence" to" highlight" the" advantages" of"
real" time"CF" sensing."However," there" is" still"more"work" to" be" done" in" this" arena," including"







does" predispose" to" unmeasured" systematic" differences" between" the" patient" groups."




choice." Furthermore," the" analysis" of" the" primary" outcome" data" was" carried" out" as" an"
intention"to"treat"analysis"in"keeping"with"a"randomised"control"trial"model."
Although" the" sample" size"was" small," the" effect" size"was" significantly" different" between" the"
two"groups"meaning"that"the"study"was"not"underpowered."




episodes" despite" the" fact" the" rigour" of" the" monitoring" schedule" was" greater" than" the"






the" CASAOAF" study" presented" in" this" thesis." I" concurrently" applied" for" a" £1.2"million" NIHR"
research"grant,"which"was"successful.""
The" forthcoming" CASAOAF" RCT" (due" to" commence" in" June" 2015)" seeks" to" provide" a" robust"
assessment" of" the" differences" between" thoracoscopic" and" catheter" ablation" techniques" in"
LSPAF." It" is" an" industryOindependent,"multiOcentre" randomised" controlled" trial." The" primary"
hypothesis" is" that" thoracoscopic" surgical" ablation" is" more" effective" than" percutaneous"
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catheter" ablation" in" LSPAF" with" regards" to" freedom" from" atrial" arrhythmia" at" 12" months’"
followOup"after"a"single"procedure"without"antiarrhythmic"drugs."The"study"will"also"evaluate,"
in" detail:" the" effect" on" LA" anatomy" and" function;" safety;" change" in" patients'" quality" of" life"
using" validated" general" and" diseaseOspecific" tools;" and" perform" a" comprehensive" health"
economic"assessment."
To" answer" the" question" about" the" importance" of" ganglionated" plexi" (GP)" ablation" in"
thoracoscopic" surgical" procedures," an" additional" subOstudy" is" planned" using" nuclear" MIBG"




Data" from" this" prospective," nonOrandomised" study" indicates" that" thoracoscopic" surgical"
ablation" achieves" superior" outcomes" with" respect" to" freedom" for" atrial" arrhythmia" at" 9"
months." However," there" is" an" increased" risk" of" major" (nonOfatal)" complications" with"
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Chief!/!Principal!Investigator!!!!!!!!!!!!!!!!!!!!!!!! ! ! ! ! Study!Coordinator!

















We"would" like" to" invite" you" to" consider" taking" part" in" a" research" study" at" the" Royal" Brompton" &"
Harefield"NHS" Foundation" Trust." " Before" you" decide" it" is" important" for" you" to" understand"why" the"
research" is" being" done" and" what" it" will" involve" for" you." Please" take" time" to" read" the" following"
information"carefully"and"discuss"it"with"others"if"you"wish."Ask"us"if"there"is"anything"that"is"not"clear"


















You" are" being" asked" to" participate" in" this" research" study" because" you" have" symptoms" (e.g."




























































































This"provides"access"to"the"areas"responsible" for"causing"AF,"which" is" the" left"upper"chamber"of" the"
heart" (left"atrium)."A"number"of" ‘heat" lesions’" (referred" to"as"ablation)"will"be"created"on" the"outer"
surface" of" the" left" atrium"by" applying" an" instrument" called" a" radiofrequency" clamp." These" ablation"
areas" will" develop" into" scars" to" isolate" the" areas" responsible" for" the" initiation" of" the" rhythm"
abnormality"allowing" the"heart" to"maintain"normal"SR."During" thoracoscopic" surgical"ablation"of"AF,"




























































































































































































































































































































Your" medical" records" will" be" made" available" for" review" by" the" study" investigators" and" regulatory"
authorities"(who"periodically"check"that"the"studies"are"being"carried"out"correctly)."The"information"in"
these"records"will"be"kept"confidential"but"on"rare"occasions"the" law"may"require"disclosure"to"third"
parties." At" the" end" of" the" project" all" the" research" results" are" gathered" together" and" analysed." The"
researchers"have"a"professional"responsibility"to"publish"their"findings,"however"your"identity"will"not"
be"revealed." "Most"research" is"published" in"the"medical"press"–" if"you"are" interested" in"knowing"the"















































































































































































































COPD/asthma" ""Y/N" " """""""""""""Smoking"""""""""""""Current!/!exX!(>3months)!/!never!
Diabetes" ""Insulin!/!tablet!/diet!/!N!!
Thyroid"" ""Hyper!/!Hypo/!N!""""""""""""""""""""""""""""
Hypertension" ""Y/N""""""""""""""""""""""""""""""""""""""""""""""""""""Renal"disease""" " Y/N"









Duration"of"AF" " " ______________"(should"be"longOstanding"persistent">1"<"5"years)!
"
Past"DC"cardioversion?" "N/"Y"O"number:"1,2,3,!>3!




Palpitation" " " """""""""""""Y/N"
Syncope" " " " Y/N"
Angina" " " " """""""""""""Y/N"
Breathlessness" " " Y/N!
Orthopnoea"(no."pillows)!! ! (n=____)!
PND" ! ! ! !!!!!!!!!!!!!Y/N"
Ankle"swelling" " " """""""""""""Y/N"
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! ! ! ! !
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Murmur" none!! ! systolic!diastolic!____________________!
"
3rd"HS" " Y/N! ! 4th"HS" " Y/N!
"























Hb"(g/dl)" " """Plts"(x109/L)" " """"WCC"(x109/L)""""""""""""""""""""""""INR"
Na""(mmol/L)" " """K"(mmol/L)" " """"Urea"(mmol/L)"""""""""""""""""""""Creat"(µmol/L)"







QRSd"(ms)" " " ______"
Axis"(degrees)" " " ______"

























































JVP:""" " normal!raised! ! markedly!raised!(>10cm)!
"
Murmur" none!! ! systolic!diastolic!____________________!
"
3rd"HS" " Y/N! ! 4th"HS" " Y/N!
"













































































JVP:""" " normal!raised! ! markedly!raised!(>10cm)!
"
Murmur" none!! ! systolic!diastolic!____________________!
"
3rd"HS" " Y/N! ! 4th"HS" " Y/N!
"
































































JVP:""" " normal!raised! ! markedly!raised!(>10cm)!
"
Murmur" none!! ! systolic!diastolic!____________________!
"
3rd"HS" " Y/N! ! 4th"HS" " Y/N!
"























































































JVP:""" " normal!raised! ! markedly!raised!(>10cm)!
"
Murmur" none!! ! systolic!diastolic!____________________!
"
3rd"HS" " Y/N! ! 4th"HS" " Y/N!
"
















































































""""""""""""""" Baseline! " " " " " "
!!!!!!!!!!!!!!!!! PVI! " Y/N" " " " "
! Roof!line! " Y/N" " " " "
! MVI!line! " Y/N" " " " "
" Epicardial"CS" " " " " " "
! CFAE" " " " " " "
" Other"(redo)"
___________"
" " " " " "
" SVC"iso"(redo" " " " " " "
! CTI"(redo)" " Y/N" " " " "
"
End"time"(sheaths"out)"_____________________"
Termination"of"AF" No!! To!AT!(__________________________________________________)! !To!SR" "





Rhythm!at!discharge!! SR! AF!! AT!! other!________________!
ITU"stay"if"needed"(days)______________" " " " Hospital"stay"(days)"__"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
Log!all!time!points!on!Bard!–!annotate!all!geometry!and!CFE!maps!!
!!
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CASAXAF!Thoracoscopic!AF!Ablation!Protocol!
"
"
CASAOAF"Study"ID" """""""""""""""""""""""""""""""""""""""""""""""""""""""" """""""""""""Date""
"
Site"""""""""""""""""""""""""""""""""""""""""!"
"""""""
"
Operator""""
"
"
Type"of"EP"Catheter"Used"
"
"
"
Procedure"Start"Time"""
"
!
Lesion"Set"""""""""""""""""""""""""""""""""""PVI"+"GP"Ablation"+"Box"Lesion"(Superior"&"Inferior"Line)"
!
RIGHT!SIDE!
!
Baseline!PV!Testing!preXablation!!
Surgical"pen""
""""""""""""""
EP"Catheter"
"
"
"
"
"
"
"
"
"
"
"
Post!PVI!Entrance!Block"(surgical"pen"on"PV"side"of"line"–"absent"potentials)"""""
"
Initial!GP!Mapping"""""""+ve"/"Ove"
"
"
"
"
"
"
"
Right!PV!Bipolar!Clamp!Ablations!!!!!!!!(document"no."of"seconds"for"each"application)!
"
"
"
"
"
Total"No"of"Applications"
"
Inferior!Box!Line!Ablation!!!!!!!!!!!!!!!!!!!!!!(document"no."of"seconds"for"each"application)!
!
!
!!
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"
"
"
"
"
"
"
"
"
"
"
!
"
"
"
"
"
"
"
"
"
"
Post!Ablation!GP!Mapping""+ve"/"Ove""""""(should"have"no"remaining"vagal"effect)"
"
"
"
"
"
"
"
"
"
"
"
"
"
"
LEFT!SIDE!
!
Baseline!PV!Testing!preXablation!!
Surgical"pen""
""""""""""""""
EP"Catheter"
!
!
!
"
"
"
"
"
Total"No"of"Applications"
!
GP!Ablation!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!(document"no."of"seconds"for"each"application)!
"
"
"
"
"
Total"No"of"Applications"
!
Superior!Box!(Roof)!Line!Ablation"""""(document"no."of"seconds"for"each"application)""""
""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""(line"done"from"LSPV"towards"RSPV)"
"
"
"
"
"
"
Total"No"of"Applications"
"
Left!PV!Bipolar!Clamp!Ablations!
"
!!
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"
"
"
"
"
"
"
"
"
!
!
Post!PVI!Entrance!Block""
Surgical"pen"O"PV"side"of"line""
EP"Catheter"
"
"
"
"
DCCV!to!SR!(No."of"times"and"Joules"used)!
!
!
!
!
Box!Lesion!Entrance!Block""O"Surgical"Pen"/"EP"Catheter"within"Box"–"Quiet?"
!
Box!Lesion!Exit!Block!
Pace"within"box"to"show"outside"of"box"(PV"antrum)"is"not"capturing"
"
Left!PV!Exit!Block!
Pace"PV"side"of"PVI"line"to"show"body"of"atrium"(via"surface"ECG)"not"capturing""
"
"
SWITCH!BACK!to!RIGHT!SIDE!FOR!TESTING!!
!
Right!PV!Exit!Block!
Pace"PV"side"of"PVI"line"to"show"body"of"atrium"(via"surface"ECG)"not"capturing"
"
"
ReXtest!Right!PV!Entrance!Block!with!EP!Catheter!
"
"
"
!
Complications"
"
"
"
"
"
"
Total"No"of"Applications"
!
!
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"
"
"
Notes"
"
"
"
"
Finish"Time"""
"
"
Total"Time"!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!
!
!
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EHRA!Score!
!
!
!
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